var title_f16_37_16976="Nail pits aa";
var content_f16_37_16976=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F73527&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F73527&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Nail pitting",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Numerous pits are present in this nail from a patient with alopecia areata.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_37_16976=[""].join("\n");
var outline_f16_37_16976=null;
var title_f16_37_16977="Stereotactic breast biopsy PI";
var content_f16_37_16977=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F86544&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F86544&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 523px\">",
"   <div class=\"ttl\">",
"    Stereotactic breast biopsy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 503px; height: 482px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    During a stereotactic breast biopsy, you lie face down on a table with your breast through a hole. Your breast is pressed between 2 metal plates, just like it would be during a mammogram. The machine takes X-rays from different angles. The images let the doctor see where to place the needle for the biopsy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_37_16977=[""].join("\n");
var outline_f16_37_16977=null;
var title_f16_37_16978="Patient information: Cadmium toxicity (Cadmium poisoning) (The Basics)";
var content_f16_37_16978=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"17\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?27/35/28212\">",
"         Patient information: Chronic kidney disease (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?4/59/5043\">",
"         Patient information: Chronic obstructive pulmonary disease (COPD), including emphysema (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?36/31/37363\">",
"         Patient information: Glomerular disease (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?34/58/35746\">",
"         Patient information: Osteoporosis (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?1/29/1491\">",
"         Patient information: Bone density testing (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?36/35/37426\">",
"         Patient information: Glomerular disease overview (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Cadmium toxicity (Cadmium poisoning) (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/cadmium-toxicity-cadmium-poisoning-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H10195323\">",
"      <span class=\"h1\">",
"       What is cadmium toxicity (cadmium poisoning)?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Cadmium toxicity is a serious medical problem that happens when cadmium gets into your body. It can cause problems with the kidneys, bones, and lungs. The word &ldquo;toxic&rdquo; means poisonous.",
"     </p>",
"     <p>",
"      Cadmium is a metal that can be in many common things. These include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Metal objects",
"       </li>",
"       <li>",
"        Cigarettes",
"       </li>",
"       <li>",
"        Paint",
"       </li>",
"       <li>",
"        Batteries",
"       </li>",
"       <li>",
"        Fertilizer",
"       </li>",
"       <li>",
"        Food &ndash; Foods can be toxic if they grow in soil with cadmium in it. Grain, rice, and vegetables are some foods that pick up cadmium easily from the soil where they grow.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Cadmium can also get into the air. This is happens most often around mines, smelters (places that melt down metal), and factories that use cadmium to make products such as batteries. People who work in mines or factories that use cadmium have a higher risk of cadmium toxicity than other people. People who live near a mine, factory, or farm that uses a lot of cadmium can also be at higher risk. &nbsp; &nbsp;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H10195338\">",
"      <span class=\"h1\">",
"       What are the symptoms of cadmium toxicity?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Cadmium toxicity can happen slowly or quickly. If it happens slowly, it might not cause any symptoms at first. But cadmium can build up inside the body over time. After years of being around it, symptoms can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Urinating more often than usual &nbsp;",
"       </li>",
"       <li>",
"        Kidney stones &ndash; Small stones that form inside the kidneys",
"       </li>",
"       <li>",
"        Bones that break easily &nbsp;",
"       </li>",
"       <li>",
"        Lung problems",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Cadmium toxicity can happen all of a sudden if a person breathes in smoke or dust with a lot of cadmium in it. If this happens, it can cause severe lung problems. A person can get very sick right away and even die.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H10195353\">",
"      <span class=\"h1\">",
"       Is there a test for cadmium toxicity?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. The doctor or nurse will do an exam and learn about your symptoms. He or she can also do the following tests:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Urine tests &ndash; These can show:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Cadmium that has built up in the kidneys over time",
"       </li>",
"       <li>",
"        How well the kidneys are working -- People with cadmium toxicity have more of certain proteins in their urine. They also have more calcium in their urine. These can be signs that the kidneys are not working as well as they should be. &nbsp;",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Blood tests &ndash; These can show cadmium in your blood. &nbsp;",
"       </li>",
"       <li>",
"        Bone density tests &ndash; These tests use special X-rays to measure your bones. If you have cadmium toxicity, your bones might be thinner and weaker than they should be.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H10195368\">",
"      <span class=\"h1\">",
"       How is cadmium toxicity treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;There is no good treatment for cadmium toxicity or the health problems it can cause. If your kidneys stop working completely, you might need to have your blood filtered by a machine. This treatment is called &ldquo;hemodialysis,&rdquo; but many people just call it &ldquo;dialysis.&rdquo; The machine takes over the kidneys&rsquo; job of getting rid of waste in the blood.",
"     </p>",
"     <p>",
"      If you breathe in a lot of cadmium at once, you will get treatment in the hospital. This usually happens in the intensive care unit (called &ldquo;ICU,&rdquo; for short). If you are having a hard time breathing, doctors can put a tube in your throat to help you breathe. The tube goes down the throat and into the lungs. The other end is attached to a machine that helps with breathing.",
"     </p>",
"     <p>",
"      If you eat something that has a lot of cadmium in it, you might have a treatment called &ldquo;chelation&rdquo; therapy. This involves taking a medicine that helps pull cadmium out of the body. But doctors give this medicine only if they are sure that you are no longer being exposed to cadmium. And getting cadmium toxicity from food does not happen very often. &nbsp;",
"     </p>",
"     <p>",
"      If the cadmium toxicity causes weak or soft bones, the doctor might prescribe large doses of vitamin D and other medicines to make bones stronger.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H10195383\">",
"      <span class=\"h1\">",
"       Can cadmium toxicity be prevented?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You can reduce your chances of getting cadmium toxicity by:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        NOT smoking &ndash; Smoking cigarettes raises your risk of cadmium toxicity.",
"       </li>",
"       <li>",
"        Eating food grown in soil without a lot of cadmium",
"       </li>",
"       <li>",
"        Using fertilizers that do not have cadmium in them &ndash; Check the label on fertilizer you use in your yard or garden.",
"       </li>",
"       <li>",
"        Asking your supervisor how to stay away from cadmium at work, if you work in:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        A factory that uses cadmium",
"       </li>",
"       <li>",
"        A farm that uses fertilizers",
"       </li>",
"       <li>",
"        A place that treats sewage (liquid waste) or garbage (solid waste). Sewage or garbage can have cadmium in it.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H10195398\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/31/37363?source=see_link\">",
"       Patient information: Glomerular disease (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?27/35/28212?source=see_link\">",
"       Patient information: Chronic kidney disease (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?34/58/35746?source=see_link\">",
"       Patient information: Osteoporosis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?4/59/5043?source=see_link\">",
"       Patient information: Chronic obstructive pulmonary disease (COPD), including emphysema (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?36/35/37426?source=see_link\">",
"       Patient information: Glomerular disease overview (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?1/29/1491?source=see_link\">",
"       Patient information: Bone density testing (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?16/37/16978?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 83756 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.69.132.100-7288C09AE7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_37_16978=[""].join("\n");
var outline_f16_37_16978=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10195323\">",
"      What is cadmium toxicity (cadmium poisoning)?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10195338\">",
"      What are the symptoms of cadmium toxicity?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10195353\">",
"      Is there a test for cadmium toxicity?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10195368\">",
"      How is cadmium toxicity treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10195383\">",
"      Can cadmium toxicity be prevented?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10195398\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/29/1491?source=related_link\">",
"      Patient information: Bone density testing (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/35/28212?source=related_link\">",
"      Patient information: Chronic kidney disease (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?4/59/5043?source=related_link\">",
"      Patient information: Chronic obstructive pulmonary disease (COPD), including emphysema (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/31/37363?source=related_link\">",
"      Patient information: Glomerular disease (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?36/35/37426?source=related_link\">",
"      Patient information: Glomerular disease overview (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?34/58/35746?source=related_link\">",
"      Patient information: Osteoporosis (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_37_16979="Classic Kaposi sarcoma - nodules";
var content_f16_37_16979=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F54707&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F54707&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Classic Kaposi sarcoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple papules and nodules are present on the lower leg in this patient with classic Kaposi sarcoma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_37_16979=[""].join("\n");
var outline_f16_37_16979=null;
var title_f16_37_16980="Cardiac catheterization PI";
var content_f16_37_16980=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F77943&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F77943&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 508px\">",
"   <div class=\"ttl\">",
"    Cardiac catheterization",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 488px; height: 630px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    For a cardiac catheterization, your doctor will make a very small cut in the top, inner part of your leg, or arm. He or she will put a thin plastic tube, called a \"catheter,\" in a blood vessel below the cut. Then he or she will move the tube through your blood vessels to your heart. When the tube is in place, your doctor can do different tests. Most people have a test called \"coronary angiography.\" For this test, your doctor will inject a dye that creates pictures to show if your heart arteries are clogged.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_37_16980=[""].join("\n");
var outline_f16_37_16980=null;
var title_f16_37_16981="Measurement of intraabdominal pressure";
var content_f16_37_16981=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F56661&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F56661&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 544px\">",
"   <div class=\"ttl\">",
"    Measurement of intraabdominal pressure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 524px; height: 634px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    1. Clamp the drainage tube of the Foley (bladder) catheter.",
"    <br>",
"     2. Instill up to 60 cc sterile saline into the bladder via the aspiration port of the Foley catheter. Be certain the catheter is filled with fluid.",
"     <br>",
"      3. Attach a pressure transducer to an 18-gauge needle, and insert into the aspiration port. With some newer style Foley catheters, a needle-less connection system can be used.",
"      <br>",
"       4. Zero the transducer at the level of the midaxillary line.",
"       <br>",
"        5. With the patient in the supine position, ensure that abdominal muscle contractions are absent, and measure the bladder pressure at end-expiration.",
"        <div class=\"footnotes\">",
"        </div>",
"        <div class=\"reference\">",
"        </div>",
"       </br>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_37_16981=[""].join("\n");
var outline_f16_37_16981=null;
var title_f16_37_16982="Epidermolysis bullosa acquisita scarring";
var content_f16_37_16982=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86482&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86482&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Epidermolysis bullosa acquisita",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 405px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Scarring and milia on the dorsal hands in epidermolysis bullosa acquisita.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_37_16982=[""].join("\n");
var outline_f16_37_16982=null;
var title_f16_37_16983="Cerebral edema in children with diabetic ketoacidosis";
var content_f16_37_16983=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Cerebral edema in children with diabetic ketoacidosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/37/16983/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/37/16983/contributors\">",
"     George S Jeha, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/37/16983/contributors\">",
"     Morey W Haymond, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/37/16983/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/37/16983/contributors\">",
"     Joseph I Wolfsdorf, MB, BCh",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/37/16983/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/37/16983/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/37/16983/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 12, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cerebral edema is an uncommon but potentially devastating consequence of diabetic ketoacidosis (DKA). It is far more common among children with DKA than among adults. Young children and those with newly diagnosed diabetes are at highest risk. Symptoms typically emerge during treatment for DKA, but may be present prior to initiation of therapy.",
"   </p>",
"   <p>",
"    The pathophysiology, diagnosis, and treatment of cerebral edema in children with diabetic ketoacidosis will be discussed here. The diagnosis and treatment of diabetic ketoacidosis in children is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/32/41480?source=see_link\">",
"     \"Clinical features and diagnosis of diabetic ketoacidosis in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/28/7626?source=see_link\">",
"     \"Treatment and complications of diabetic ketoacidosis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INCIDENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinically significant cerebral edema occurs in approximately 1 percent of episodes of diabetic ketoacidosis in children and has a mortality rate of 20 to 90 percent; 50 to 80 percent of diabetes-related deaths are caused by cerebral edema [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. Overall mortality rates for diabetic ketoacidosis (DKA) in children range from 0.15 to 0.51 percent in national population studies in Canada, the United Kingdom, and the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/4-7\">",
"     4-7",
"    </a>",
"    ]. Other causes of death from DKA include aspiration pneumonia, multiple organ failure, gastric perforation, and traumatic hydrothorax [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Subclinical brain swelling, as detected by ventricular narrowing on a CT scan, has been reported in the majority of children with DKA in some studies [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/8,9\">",
"     8,9",
"    </a>",
"    ], while others reported much smaller proportions [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/10\">",
"     10",
"    </a>",
"    ]. All of these studies were limited by small numbers and lack of appropriate control groups.",
"   </p>",
"   <p>",
"    In a study of 41 children with DKA, the intercaudate width of the frontal horns of the lateral ventricles was measured by magnetic resonance imaging (MRI) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/11\">",
"     11",
"    </a>",
"    ]. The lateral ventricles were significantly smaller in patients during treatment for DKA than after recovery (mean width 9.3 &plusmn; 0.3 versus 10.2 &plusmn; 0.3 mm, respectively). Fifty-six percent of the children had ventricular narrowing during treatment, and these children were more likely to have mental status changes than those without narrowed ventricles (Glasgow coma scale scores below 15 occurred in 12 of 22 with ventricular narrowing, versus 4 of 19 without).",
"   </p>",
"   <p>",
"    Despite the lack of a control group, these findings suggest that cerebral swelling occurs commonly in children with DKA. However, it remains unclear whether subclinical brain swelling noted in this study is a precursor to clinically significant cerebral edema and if so, what factors determine progression. Similar changes in mental status have been reported among children with other causes of acidosis, so it is difficult to determine whether the observed mental status changes in this study are due to the cerebral edema or to the underlying acidosis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/11,12\">",
"     11,12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9915119\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cause of cerebral edema in DKA is not fully understood, and the only definite way to prevent it is to avoid DKA [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/13\">",
"     13",
"    </a>",
"    ]. Although in the past decade multiple studies have increased our understanding, they all have substantial limitations, including the retrospective nature of the studies, the heterogeneity in the management of each of the patients, and their small sample sizes. These limitations are inevitable given the rare and unpredictable nature of cerebral edema in DKA. Nonetheless, such studies provide general principles for management that are considered safe and are summarized by several consensus statements [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/1,14\">",
"     1,14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cerebral edema may be present before treatment has begun, but more commonly occurs 4 to 12 hours after the initiation of therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/5,8,9,14-17\">",
"     5,8,9,14-17",
"    </a>",
"    ]. Thus, therapy may exacerbate but not initiate the pathologic process(es) leading to cerebral edema.",
"   </p>",
"   <p>",
"    Numerous factors have been implicated in the pathophysiology of DKA-related cerebral edema, but none has been proven. Ischemic, vasogenic, osmotic, or cytotoxic processes have been proposed, as discussed below. It is possible that DKA-related cerebral edema is due to a combination of two or more of these factors. In addition, other metabolic and inflammatory factors, such as hyperglycemia-induced increase in blood-brain barrier permeability, and the generation of new solutes within the brain by hyperglycemia itself and by insulin therapy may contribute to its pathogenesis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/18-21\">",
"     18-21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/58/23464?source=see_link\">",
"     \"Manifestations of hyponatremia and hypernatremia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13223642\">",
"    <span class=\"h2\">",
"     Proposed mechanisms",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Ischemia/cytotoxic edema",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies utilizing proton MR spectroscopy have shown a decrease of N-acetylaspartate (NAA), a marker of neuronal function or viability, in children with DKA in several areas of the brain, including the basal ganglia and occipital and peri-aqueductal gray matter. These observations suggest, therefore, that cerebral ischemia may play a role in the pathophysiology of DKA-related cerebral edema [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/22\">",
"     22",
"    </a>",
"    ], a hypothesis further supported by several observations including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Increased lactate production in the basal ganglia in children with DKA [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Breakdown in blood-brain barrier, decrease in neuronal density, and increases in pro-inflammatory mediators and cytotoxic markers in fatal cases of cerebral edema [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/24-26\">",
"       24-26",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Vasogenic edema",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term \"vasogenic\" edema describes a process in which primary damage to the cerebral vascular endothelium results in increased blood-brain barrier permeability or a disturbance in autoregulation, which permits abnormal diffusion of intravascular fluids into the cerebral tissues. A variety of observations suggest that this mechanism is an important contributor to cerebral edema in the setting of DKA: Studies using MRI imaging demonstrate water diffusion into cerebral tissues during treatment for DKA [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/27,28\">",
"     27,28",
"    </a>",
"    ] while others suggest an abnormality in blood-brain barrier permeability [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/29\">",
"     29",
"    </a>",
"    ]. Normal or increased cerebral blood flow and oxygenation has been observed despite hypocapnia, suggesting defective vascular autoregulation [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. Together, these studies support the idea of a vasogenic mechanism for fluid shifts into the brain during treatment for DKA. &nbsp;",
"   </p>",
"   <p>",
"    These studies are small and examine children undergoing treatment for DKA, but without clinical evidence of cerebral edema. It remains unclear whether these observations also describe the mechanisms underlying the more dramatic fluid shifts that occur in children who develop clinically significant cerebral edema.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Osmotic edema as a consequence of fluid therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the extracellular compartment is at a lower osmolarity than the intracellular compartment, osmotic pressure promotes water movement into the intracellular compartment. During DKA, the combination of insulin and fluid repletion lowers the serum glucose and plasma osmolality, promoting osmotic water movement into the brain [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/18-20\">",
"     18-20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This mechanism provides a logical explanation for the development of cerebral edema as a result of the osmotic changes that occur during treatment for DKA. However, these fluid shifts happen in all patients with DKA, yet only approximately 1 percent of patients develop clinically significant cerebral edema. Proponents of this hypothesis advocate the use of &ldquo;physiologic management&rdquo; of DKA that includes a planned replacement of fluid and electrolyte deficits over 48 hours and strongly argue that such an approach reduces the risk of cerebral edema. In one report of patients managed by this method, fluid replacement actually occurred much faster than planned (fluid replacement was complete around 12 hours of therapy rather than 48 hours as planned) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/31\">",
"     31",
"    </a>",
"    ]. The proportion of patients treated for cerebral edema was not lower as compared with other series, perhaps because patients were identified and treated at earlier stages of symptomatology. Remarkably, there was zero mortality and morbidity from cerebral edema in this series. These observations suggest that early identification of cerebral edema and aggressive intervention with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?42/60/43975?source=see_link\">",
"     mannitol",
"    </a>",
"    can help eliminate mortality and morbidity, but do not independently support the efficacy of &ldquo;physiologic management&rdquo;.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several risk factors for developing cerebral edema in children with DKA have been identified [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/1,14,17\">",
"     1,14,17",
"    </a>",
"    ]. Some of these risk factors may merely reflect a longer period of symptoms prior to diagnosis with a greater likelihood of presenting with severe DKA.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Younger children [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/2,5,32\">",
"       2,5,32",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Children with newly diagnosed diabetes [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/2,3\">",
"       2,3",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Failure of the serum sodium to rise as predicted following insulin therapy and fluid repletion, indicating a greater fall in plasma osmolality [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/18,33-36\">",
"       18,33-36",
"      </a>",
"      ]; in one report, for example, the effective plasma osmolality fell significantly more in patients who developed cerebral edema compared to those who did not (9 versus 1 to 2",
"      <span class=\"nowrap\">",
"       mOsmol/kg",
"      </span>",
"      at four hours) [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/33\">",
"       33",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Increased blood urea nitrogen at presentation of DKA, which may represent a greater degree of hypovolemia [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/2,7\">",
"       2,7",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      The severity of acidosis at presentation [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/7,19,37\">",
"       7,19,37",
"      </a>",
"      ], although acidosis was not important in an animal model [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/20\">",
"       20",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      The use of bicarbonate therapy for correction of the acidosis in DKA [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/2,38\">",
"       2,38",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      After adjusting for the severity of acidosis, a lower initial partial pressure of arterial carbon dioxide [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/2,39\">",
"       2,39",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Studies conflict in their conclusions about whether the rate of fluid or insulin administration is associated with an increased risk of cerebral edema, perhaps because of the difficulty of designing adequate controls for this type of study. Several studies have suggested that rapid correction of dehydration using hypotonic fluids increases intracranial pressure in patients with DKA [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/33,37,39,40\">",
"     33,37,39,40",
"    </a>",
"    ]. Similarly, the administration of greater amounts of insulin during the initial phases of treatment may increase the risk of cerebral edema [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/33,37\">",
"     33,37",
"    </a>",
"    ]. However, a larger and well-designed study did not identify either rate of fluid or insulin administration as a risk factor [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/2\">",
"     2",
"    </a>",
"    ]. Given the lack of definite answers, we suggest cautious use of fluids and insulin to minimize any possible risks.",
"   </p>",
"   <p>",
"    In our current practice, we avoid the use of bicarbonate and aim for an appropriate rise in serum sodium concentration as the glucose concentration falls. We try to correct the effective circulating volume gradually. In the initial stages, we restore glomerular filtration rate with isotonic fluid, and avoid hypotonic solutions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     SIGNS AND SYMPTOMS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presentation of cerebral edema varies but the onset of headache is usually the earliest symptom. Altered level of consciousness, sustained heart rate deceleration, or age-inappropriate incontinence are important early signs of impending neurologic collapse [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/1\">",
"     1",
"    </a>",
"    ]. These symptoms often occur prior to notable changes in head computed tomography. Frequent monitoring at the bedside for early symptoms of cerebral edema may identify these children sufficiently early for intervention to prevent brain damage [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/41\">",
"     41",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Treatment'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/37/44633?source=see_link\">",
"     \"Elevated intracranial pressure in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Bedside evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following criteria may be helpful in identifying children who may progress to severe, life-threatening cerebral edema [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/1,41\">",
"     1,41",
"    </a>",
"    ]. The presence of any of the symptoms listed below should raise suspicion for the possibility of cerebral edema. Children with severe DKA can have an altered mental status that is due to other factors including the degree of dehydration, metabolic derangements, and sleep deprivation. Nonetheless, clinicians should maintain a high level of suspicion for evidence of cerebral edema and intervene promptly if the diagnosis is suspected. By the time the diagnostic criteria develop, cerebral edema is already in an advanced stage, and morbidity and mortality are high [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/3,14,17,41\">",
"     3,14,17,41",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Cerebral edema is diagnosed if any of the diagnostic criteria listed below is present. Cerebral edema is also likely if two major criteria",
"    <strong>",
"     OR",
"    </strong>",
"    one major and two minor criteria are present (",
"    <a class=\"graphic graphic_table graphicRef53017 \" href=\"UTD.htm?3/3/3132\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Diagnostic criteria",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Abnormal motor or verbal response to pain",
"     </li>",
"     <li>",
"      Decorticate or decerebrate posture",
"     </li>",
"     <li>",
"      Cranial nerve palsy (especially III, IV, and VI)",
"     </li>",
"     <li>",
"      Abnormal neurogenic respiratory pattern (eg, grunting, tachypnea, Cheyne-Stokes respiration, apneusis)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Major criteria",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Altered",
"      <span class=\"nowrap\">",
"       mentation/fluctuating",
"      </span>",
"      level of consciousness",
"     </li>",
"     <li>",
"      Sustained heart rate deceleration (decline more than 20 beats per minute) not attributable to improved intravascular volume or sleep state",
"     </li>",
"     <li>",
"      Age-inappropriate incontinence",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Minor criteria",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Vomiting",
"     </li>",
"     <li>",
"      Headache",
"     </li>",
"     <li>",
"      Lethargy or not easily aroused from sleep",
"     </li>",
"     <li>",
"      Diastolic blood pressure &gt;90 mmHg",
"     </li>",
"     <li>",
"      Age &lt;5 years",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;An essential part of therapy in DKA is careful monitoring for changes in mental or neurologic status that would permit early identification and therapy of cerebral edema. As soon as cerebral edema is suspected, treatment should be initiated. The 2004",
"    <span class=\"nowrap\">",
"     ESPE/LWPES",
"    </span>",
"    consensus statement recommends the following [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/14,17\">",
"     14,17",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The rate of fluid administration should be reduced.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?42/60/43975?source=see_link\">",
"       Mannitol",
"      </a>",
"      should be given at 0.25 to 1.0",
"      <span class=\"nowrap\">",
"       g/kg",
"      </span>",
"      intravenously over 20 minutes. The mannitol dose may be repeated in two hours, if there is no initial response. This recommendation is based upon the suggested beneficial effect of mannitol in case reports [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/42-44\">",
"       42-44",
"      </a>",
"      ]. In a retrospective study of 61 patients with cerebral edema, mannitol did not appear to have either a beneficial or detrimental effect [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/45\">",
"       45",
"      </a>",
"      ]. However, the majority of patients in this study presented with symptoms suggesting severe cerebral edema, so these results should not be interpreted to suggest that mannitol is ineffective in earlier stages of cerebral edema.",
"     </li>",
"     <li>",
"      3 percent saline (5 to 10",
"      <span class=\"nowrap\">",
"       mL/kg",
"      </span>",
"      over 30 minutes), has been used as an alternative hypertonic agent, but clinical experience is limited [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/46,47\">",
"       46,47",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Intubation and mechanical ventilation may be required. However, hyperventilation should be avoided and has been associated with a poor outcome in patients whose pCO2 was driven below 22 mmHg [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/45\">",
"       45",
"      </a>",
"      ]. Aggressive hyperventilation (beyond the baseline hyperventilation present in most patients with DKA) may decrease cerebral blood flow enough to cause cerebral ischemia and actually increase the extent of brain injury in any form of cerebral edema. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/37/44633?source=see_link&amp;anchor=H25#H25\">",
"       \"Elevated intracranial pressure in children\", section on 'Hyperventilation'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     OUTCOME",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mortality rate among children with DKA who develop cerebral edema is approximately 20 to 25 percent; among survivors, approximately 15 to 35 percent have permanent sequelae [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/1,3,45\">",
"     1,3,45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Risk factors for death or survival in a vegetative state were identified in a retrospective multicenter study of 61 children [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16983/abstract/45\">",
"     45",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Elevated blood urea nitrogen at the time of initial presentation.",
"     </li>",
"     <li>",
"      Intubation with hyperventilation with a pCO2 of less than 22 mmHg.",
"     </li>",
"     <li>",
"      Severe neurologic compromise at presentation. All patients who either died or survived in a persistent vegetative state presented with a Glasgow coma score &le;7 (score of 6 to 7 includes an abnormal or absent purposeful response to pain scores) (",
"      <a class=\"graphic graphic_table graphicRef59662 \" href=\"UTD.htm?2/58/2989\">",
"       table 2",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    No prospective studies have been performed to determine if early identification of children with cerebral edema can reduce morbidity and mortality. Nonetheless, given the poor outcomes cited above, we recommend that concerted efforts be made to identify and treat children with cerebral edema.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cerebral edema is responsible for 50 to 80 percent of deaths related to diabetic ketoacidosis in children. Among children with DKA who develop cerebral edema, the mortality rate is 20 to 25 percent, and 15 to 35 percent of survivors have permanent neurologic sequelae. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children who are younger, newly diagnosed with DKA, or who present with elevated BUN, more profound acidosis, or neurologic symptoms are at greatest risk for cerebral edema. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend careful evaluation and monitoring for signs and symptoms of cerebral edema in all children undergoing treatment for DKA (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). Specific signs of increased intracranial pressure and changes detectable by head computed tomography often occur too late for effective intervention. Therefore, we recommend monitoring for symptoms that may occur earlier in the development of cerebral edema. These symptoms include headache, recurrent vomiting, and altered level of consciousness, as outlined in the bedside evaluation protocol (",
"      <a class=\"graphic graphic_table graphicRef53017 \" href=\"UTD.htm?3/3/3132\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Signs and symptoms'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Changes detectable by head computed tomography occur late in the development of cerebral edema. Therefore, the decision to treat should be based on clinical evaluation. Imaging may be useful to exclude other causes of neurological deterioration, but should not delay treatment.",
"     </li>",
"     <li>",
"      If cerebral edema is suspected, we recommend beginning treatment promptly by reducing the rate of fluid administration (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ) and administering",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?42/60/43975?source=see_link\">",
"       mannitol",
"      </a>",
"      (0.25 to 1.0",
"      <span class=\"nowrap\">",
"       g/kg)",
"      </span>",
"      (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ) or hypertonic (3 percent) saline. Mechanical hyperventilation is generally not recommended. Treatment options have not been rigorously studied, but prompt and aggressive treatment is appropriate given the high morbidity and mortality of cerebral edema. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/1\">",
"      Wolfsdorf J, Glaser N, Sperling MA, American Diabetes Association. Diabetic ketoacidosis in infants, children, and adolescents: A consensus statement from the American Diabetes Association. Diabetes Care 2006; 29:1150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/2\">",
"      Glaser N, Barnett P, McCaslin I, et al. Risk factors for cerebral edema in children with diabetic ketoacidosis. The Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. N Engl J Med 2001; 344:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/3\">",
"      Edge JA, Hawkins MM, Winter DL, Dunger DB. The risk and outcome of cerebral oedema developing during diabetic ketoacidosis. Arch Dis Child 2001; 85:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/4\">",
"      Levitsky L. Death from diabetes (DM) in hospitalized children (1970-1988). Pediatr Res 1991; 29:A195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/5\">",
"      Edge JA, Ford-Adams ME, Dunger DB. Causes of death in children with insulin dependent diabetes 1990-96. Arch Dis Child 1999; 81:318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/6\">",
"      Curtis JR, To T, Muirhead S, et al. Recent trends in hospitalization for diabetic ketoacidosis in ontario children. Diabetes Care 2002; 25:1591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/7\">",
"      Lawrence SE, Cummings EA, Gaboury I, Daneman D. Population-based study of incidence and risk factors for cerebral edema in pediatric diabetic ketoacidosis. J Pediatr 2005; 146:688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/8\">",
"      Krane EJ, Rockoff MA, Wallman JK, Wolfsdorf JI. Subclinical brain swelling in children during treatment of diabetic ketoacidosis. N Engl J Med 1985; 312:1147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/9\">",
"      Hoffman WH, Steinhart CM, el Gammal T, et al. Cranial CT in children and adolescents with diabetic ketoacidosis. AJNR Am J Neuroradiol 1988; 9:733.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/10\">",
"      Smedman L, Escobar R, Hesser U, Persson B. Sub-clinical cerebral oedema does not occur regularly during treatment for diabetic ketoacidosis. Acta Paediatr 1997; 86:1172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/11\">",
"      Glaser NS, Wootton-Gorges SL, Buonocore MH, et al. Frequency of sub-clinical cerebral edema in children with diabetic ketoacidosis. Pediatr Diabetes 2006; 7:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/12\">",
"      Edge JA, Roy Y, Bergomi A, et al. Conscious level in children with diabetic ketoacidosis is related to severity of acidosis and not to blood glucose concentration. Pediatr Diabetes 2006; 7:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/13\">",
"      Levitsky LL. Symptomatic cerebral edema in diabetic ketoacidosis: the mechanism is clarified but still far from clear. J Pediatr 2004; 145:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/14\">",
"      Dunger DB, Sperling MA, Acerini CL, et al. ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents. Arch Dis Child 2004; 89:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/15\">",
"      Alberti KG, Emerson PM, Darley JH, Hockaday TD. 2,3-Diphosphoglycerate and tissue oxygenation in uncontrolled diabetes mellitus. Lancet 1972; 2:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/16\">",
"      Glasgow AM. Devastating cerebral edema in diabetic ketoacidosis before therapy. Diabetes Care 1991; 14:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/17\">",
"      Dunger DB, Sperling MA, Acerini CL, et al. European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society consensus statement on diabetic ketoacidosis in children and adolescents. Pediatrics 2004; 113:e133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/18\">",
"      Harris GD, Fiordalisi I, Harris WL, et al. Minimizing the risk of brain herniation during treatment of diabetic ketoacidemia: a retrospective and prospective study. J Pediatr 1990; 117:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/19\">",
"      Durr JA, Hoffman WH, Sklar AH, et al. Correlates of brain edema in uncontrolled IDDM. Diabetes 1992; 41:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/20\">",
"      Silver SM, Clark EC, Schroeder BM, Sterns RH. Pathogenesis of cerebral edema after treatment of diabetic ketoacidosis. Kidney Int 1997; 51:1237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/21\">",
"      Arieff AI, Kleeman CR. Studies on mechanisms of cerebral edema in diabetic comas. Effects of hyperglycemia and rapid lowering of plasma glucose in normal rabbits. J Clin Invest 1973; 52:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/22\">",
"      Wootton-Gorges SL, Buonocore MH, Kuppermann N, et al. Cerebral proton magnetic resonance spectroscopy in children with diabetic ketoacidosis. AJNR Am J Neuroradiol 2007; 28:895.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/23\">",
"      Wootton-Gorges SL, Buonocore MH, Kuppermann N, et al. Detection of cerebral {beta}-hydroxy butyrate, acetoacetate, and lactate on proton MR spectroscopy in children with diabetic ketoacidosis. AJNR Am J Neuroradiol 2005; 26:1286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/24\">",
"      Hoffman WH, Andjelkovic AV, Zhang W, et al. Insulin and IGF-1 receptors, nitrotyrosin and cerebral neuronal deficits in two young patients with diabetic ketoacidosis and fatal brain edema. Brain Res 2010; 1343:168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/25\">",
"      Hoffman WH, Artlett CM, Zhang W, et al. Receptor for advanced glycation end products and neuronal deficit in the fatal brain edema of diabetic ketoacidosis. Brain Res 2008; 1238:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/26\">",
"      Hoffman WH, Stamatovic SM, Andjelkovic AV. Inflammatory mediators and blood brain barrier disruption in fatal brain edema of diabetic ketoacidosis. Brain Res 2009; 1254:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/27\">",
"      Glaser NS, Wootton-Gorges SL, Marcin JP, et al. Mechanism of cerebral edema in children with diabetic ketoacidosis. J Pediatr 2004; 145:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/28\">",
"      Figueroa RE, Hoffman WH, Momin Z, et al. Study of subclinical cerebral edema in diabetic ketoacidosis by magnetic resonance imaging T2 relaxometry and apparent diffusion coefficient maps. Endocr Res 2005; 31:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/29\">",
"      Vavilala MS, Richards TL, Roberts JS, et al. Change in blood-brain barrier permeability during pediatric diabetic ketoacidosis treatment. Pediatr Crit Care Med 2010; 11:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/30\">",
"      Roberts JS, Vavilala MS, Schenkman KA, et al. Cerebral hyperemia and impaired cerebral autoregulation associated with diabetic ketoacidosis in critically ill children. Crit Care Med 2006; 34:2217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/31\">",
"      Fiordalisi I, Novotny WE, Holbert D, et al. An 18-yr prospective study of pediatric diabetic ketoacidosis: an approach to minimizing the risk of brain herniation during treatment. Pediatr Diabetes 2007; 8:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/32\">",
"      Rosenbloom AL. Intracerebral crises during treatment of diabetic ketoacidosis. Diabetes Care 1990; 13:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/33\">",
"      Hoorn EJ, Carlotti AP, Costa LA, et al. Preventing a drop in effective plasma osmolality to minimize the likelihood of cerebral edema during treatment of children with diabetic ketoacidosis. J Pediatr 2007; 150:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/34\">",
"      Duck SC, Weldon VV, Pagliara AS, Haymond MW. Cerebral edema complicating therapy for diabetic ketoacidosis. Diabetes 1976; 25:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/35\">",
"      Duck SC, Wyatt DT. Factors associated with brain herniation in the treatment of diabetic ketoacidosis. J Pediatr 1988; 113:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/36\">",
"      Hale PM, Rezvani I, Braunstein AW, et al. Factors predicting cerebral edema in young children with diabetic ketoacidosis and new onset type I diabetes. Acta Paediatr 1997; 86:626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/37\">",
"      Edge JA, Jakes RW, Roy Y, et al. The UK case-control study of cerebral oedema complicating diabetic ketoacidosis in children. Diabetologia 2006; 49:2002.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/38\">",
"      Bureau MA, B&eacute;gin R, Berthiaume Y, et al. Cerebral hypoxia from bicarbonate infusion in diabetic acidosis. J Pediatr 1980; 96:968.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/39\">",
"      Mahoney CP, Vlcek BW, DelAguila M. Risk factors for developing brain herniation during diabetic ketoacidosis. Pediatr Neurol 1999; 21:721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/40\">",
"      Clements RS Jr, Blumenthal SA, Morrison AD, Winegrad AI. Increased cerebrospinal-fluid pressure during treatment of diabetic ketosis. Lancet 1971; 2:671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/41\">",
"      Muir AB, Quisling RG, Yang MC, Rosenbloom AL. Cerebral edema in childhood diabetic ketoacidosis: natural history, radiographic findings, and early identification. Diabetes Care 2004; 27:1541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/42\">",
"      Franklin B, Liu J, Ginsberg-Fellner F. Cerebral edema and ophthalmoplegia reversed by mannitol in a new case of insulin-dependent diabetes mellitus. Pediatrics 1982; 69:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/43\">",
"      Shabbir N, Oberfield SE, Corrales R, et al. Recovery from symptomatic brain swelling in diabetic ketoacidosis. Clin Pediatr (Phila) 1992; 31:570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/44\">",
"      Roberts MD, Slover RH, Chase HP. Diabetic ketoacidosis with intracerebral complications. Pediatr Diabetes 2001; 2:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/45\">",
"      Marcin JP, Glaser N, Barnett P, et al. Factors associated with adverse outcomes in children with diabetic ketoacidosis-related cerebral edema. J Pediatr 2002; 141:793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/46\">",
"      Kamat P, Vats A, Gross M, Checchia PA. Use of hypertonic saline for the treatment of altered mental status associated with diabetic ketoacidosis. Pediatr Crit Care Med 2003; 4:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16983/abstract/47\">",
"      Curtis JR, Bohn D, Daneman D. Use of hypertonic saline in the treatment of cerebral edema in diabetic ketoacidosis (DKA). Pediatr Diabetes 2001; 2:191.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5829 Version 14.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-61.234.146.186-B1BE4F5CD0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_37_16983=[""].join("\n");
var outline_f16_37_16983=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INCIDENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9915119\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13223642\">",
"      Proposed mechanisms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Ischemia/cytotoxic edema",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Vasogenic edema",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Osmotic edema as a consequence of fluid therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      SIGNS AND SYMPTOMS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Bedside evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      OUTCOME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5829\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5829|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/3/3132\" title=\"table 1\">",
"      DKA neuro state children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/58/2989\" title=\"table 2\">",
"      Glasgow and pediatric coma scales",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/32/41480?source=related_link\">",
"      Clinical features and diagnosis of diabetic ketoacidosis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/37/44633?source=related_link\">",
"      Elevated intracranial pressure in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/58/23464?source=related_link\">",
"      Manifestations of hyponatremia and hypernatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/28/7626?source=related_link\">",
"      Treatment and complications of diabetic ketoacidosis in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_37_16984="Introduction to hemoglobin mutations";
var content_f16_37_16984=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Introduction to hemoglobin mutations",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/37/16984/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/37/16984/contributors\">",
"     Stanley L Schrier, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/37/16984/contributors\">",
"     Stephen A Landaw, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/37/16984/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/37/16984/contributors\">",
"     William C Mentzer, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/37/16984/contributors\">",
"     Donald H Mahoney, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/37/16984/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/37/16984/contributors\">",
"     Stephen A Landaw, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/37/16984/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 15, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Over 1000 different mutations of the globin chains of the human hemoglobin molecule have been discovered [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16984/abstract/1\">",
"     1",
"    </a>",
"    ]. They are classified according to the type of mutation (eg, insertion, deletion, base change), the affected globin subunit (eg, alpha chain, beta chain), and by the clinical and hematologic phenotype (",
"    <a class=\"graphic graphic_table graphicRef61649 \" href=\"UTD.htm?17/10/17579\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef62517 \" href=\"UTD.htm?8/43/8892\">",
"     table 2",
"    </a>",
"    ). This topic review will present an introduction to the most common of these mutations. Sickle hemoglobin and the thalassemias are discussed separately.",
"   </p>",
"   <p>",
"    Laboratory and DNA-based methods for separation and detection of hemoglobin mutations are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/60/968?source=see_link\">",
"     \"Laboratory diagnosis of the hemoglobinopathies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INCIDENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;It has been estimated that in excess of 300,000 children are born in the world each year with a severe inherited disorder of hemoglobin, and that approximately 80 percent of these births occur in low- or middle-income countries [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16984/abstract/2\">",
"     2",
"    </a>",
"    ]. Accordingly, these disorders are presenting an increasing global health burden. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/51/41783?source=see_link\">",
"     \"Community public health issues and the thalassemic syndromes: Lessons from other countries\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The most important distinction that needs to be made when considering mutant hemoglobins is the frequency with which they are found in human populations. One group of mutant globin genes, including hemoglobins S, C, and E, is found at a frequency varying from 2 to 95 percent in different populations. These mutations are the product of expansion via selective",
"    <strong>",
"     external",
"    </strong>",
"    forces (eg, malaria) because, in the asymptomatic heterozygous form, they protect carriers from dying of malarial infection. These mutations are ethnic-specific, in that they are present in some human populations and not in others. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/23/20858?source=see_link\">",
"     \"Protection against malaria in the hemoglobinopathies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hemoglobin mutants in the second group exist at frequencies below 1 percent, and many times occur as spontaneous mutations in the propositus. These mutations usually have no medical consequences, but a subset can have serious abnormalities when present in the homozygous form. They are not ethnic-specific and examples of the same mutation, originating independently, can be found in any ethnic group.",
"   </p>",
"   <p>",
"    Mutant hemoglobins that have frequencies of approximately 1 to 2 percent in the population may or may not have been expanded by selection (eg, HbDLos Angeles, HbG-Philadelphia, Hb Hasharon). An alternative explanation is that these abnormal hemoglobins have a slightly higher frequency than predicted by mutational pressure alone (ie, no selection due to external forces) because of a \"founder's effect.\" This occurs when a population originates from a single \"founder\" or a small group of people that by chance had a high frequency of a particular non-selected hemoglobin mutation.",
"   </p>",
"   <p>",
"    The majority of hemoglobin mutants are not associated with any clinical manifestations. Many were discovered during the course of large population surveys. The \"classical\" diagnostic tool for the detection of new hemoglobin mutants was zone electrophoresis, which separates proteins differing in electrical charge. However, many mutant hemoglobins have normal electrophoretic mobility, and must be studied by other methods, such as high performance liquid chromatography (HPLC). A number of more sophisticated techniques have also been applied to the detection of mutant hemoglobins, including mass spectrometry and sequencing of DNA fragments generated by the polymerase chain reaction [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16984/abstract/3-7\">",
"     3-7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/60/968?source=see_link\">",
"     \"Laboratory diagnosis of the hemoglobinopathies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     QUANTITATION OF MUTANT HEMOGLOBINS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients heterozygous for a globin gene mutation, the quantitative amount of mutant hemoglobin is variable, and depends on a number of factors, such as the number of functioning genes in the individual, stability of the messenger RNA, rate of synthesis and stability of the gene product, and the efficiency with which the abnormal hemoglobin is assembled.",
"   </p>",
"   <p>",
"    In heterozygotes, beta globin mutant hemoglobins generally comprise 50 percent of the total hemoglobin in the red cell, in keeping with the presence of two beta globin genes, only one of which is abnormal. Exceptions to this rule are outlined below.",
"   </p>",
"   <p>",
"    In contrast, normal individuals have four alpha globin genes. Thus, alpha globin mutants in heterozygotes usually comprise about 25 percent of the hemolysate. This fraction increases if deletional forms of alpha thalassemia are also present in the same subject. In addition, the two tandem alpha globin genes differ in transcriptional efficiency, with alpha-2 being two to three times more efficient than alpha-1. As a result, stable mutants expressed by the alpha-2 gene tend to be relatively more abundant than those expressed by the alpha-1 gene [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16984/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/11/36025?source=see_link&amp;anchor=H2#H2\">",
"     \"Pathophysiology of alpha thalassemia\", section on 'Definitions'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Assembly of the mutant hemoglobin",
"    </span>",
"    &nbsp;&mdash;&nbsp;The proportion of normal and mutant hemoglobins in red cells of heterozygotes provides insight into the assembly of human hemoglobins [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16984/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. The great majority of beta chain mutants are synthesized at the same rate as normal beta chains, and have normal stability [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16984/abstract/11\">",
"     11",
"    </a>",
"    ]. Thus, heterozygotes would be expected to have equal amounts of normal and mutant hemoglobin. However, measurements of this proportion in heterozygotes have revealed unexpected variability, due, at least in part, to the net charge of the mutant globin chain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Positively charged beta chain mutants",
"    </span>",
"    &nbsp;&mdash;&nbsp;Positively charged beta chain mutants such as hemoglobins S, C, D-Los Angeles, and E constitute significantly less than one-half of the total hemoglobin in heterozygotes, and are reduced further in the presence of alpha thalassemia [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16984/abstract/9,10,12\">",
"     9,10,12",
"    </a>",
"    ]. As an example, for patients heterozygous for the sickle mutation, average values for the percent of HbS are reduced in proportion to the number of active alpha genes, as follows (",
"    <a class=\"graphic graphic_table graphicRef64715 \" href=\"UTD.htm?17/56/18316\">",
"     table 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef70184 \" href=\"UTD.htm?16/17/16667\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16984/abstract/13\">",
"     13",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Four alpha globin genes &mdash; 35 to 45 percent HbS",
"     </li>",
"     <li>",
"      Three alpha globin genes &mdash; 30 to 35 percent HbS",
"     </li>",
"     <li>",
"      Two alpha globin genes &mdash; 25 to 30 percent HbS",
"     </li>",
"     <li>",
"      One alpha globin gene &mdash; 17 to 25 percent HbS",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Negatively charged beta chain mutants",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many of the more negatively charged beta chain mutants in heterozygotes are present in amounts exceeding that of HbA. In two heterozygotes who had a negatively charged mutant (HbJ-Baltimore or HbJ-Iran) in conjunction with alpha thalassemia, the proportion of the mutant hemoglobin was found to be even further increased [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16984/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This analysis suggests that alterations in surface charge of the mutant globin chain contribute to different rates of assembly of the hemoglobin tetramer. This hypothesis is supported by in vitro mixing experiments with normal and mutant beta subunits, showing that when alpha chains are present in limiting amounts, mimicking the situation seen in alpha thalassemia, hemoglobins containing negatively charged mutants are formed much more readily than those containing positively charged mutants (",
"    <a class=\"graphic graphic_figure graphicRef72950 \" href=\"UTD.htm?0/58/942\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16984/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This electrostatic model of hemoglobin assembly has clinical implications. Differences in rates of assembly explain not only the low proportion of HbS in sickle cell trait (35 to 45 percent HbS, see above) but also explain why the proportion of HbS in SC red cells is 10 to 15 percent higher than in AS red cells [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16984/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. The prominent clinical manifestations of HbSC disease and their absence in sickle trait can be attributed in part to differences in the intracellular content of HbS [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16984/abstract/9\">",
"     9",
"    </a>",
"    ]. The higher proportion of HbS in SC red cells compared with AS red cells is due to the fact that the affinity of alpha subunits for beta subunits is in the following order: Beta A &gt; Beta S &gt; Beta C. This model also provides an explanation for differences in the levels of HbA2 and HbF that accompany certain hematologic disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16984/abstract/9,18,19\">",
"     9,18,19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     CLINICAL PHENOTYPES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individuals with a mutant globin gene(s) come to the attention of physicians when the mutation affects hemoglobin solubility, stability, oxygen affinity, or synthesis (",
"    <a class=\"graphic graphic_table graphicRef61649 \" href=\"UTD.htm?17/10/17579\">",
"     table 1",
"    </a>",
"    ). By far the most important are the sickle syndromes (ie, homozygous sickle cell (HbSS) disease, the compound heterozygous states, such as HbSC and Sickle cell-beta thalassemia), and the thalassemias.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Normal hemoglobin electrophoretic pattern",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the normal adult, three different hemoglobins are found on hemoglobin electrophoresis: hemoglobins A (adult), A2, and F (fetal). They are found in the following amounts (",
"    <a class=\"graphic graphic_table graphicRef64715 \" href=\"UTD.htm?17/56/18316\">",
"     table 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/29/23001?source=see_link\">",
"     \"Structure and function of normal human hemoglobins\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Hemoglobin F (two alpha chains and two gamma chains) &mdash; less than 1 percent",
"     </li>",
"     <li>",
"      Hemoglobin A2 (two alpha chains and two delta chains) &mdash; 2 to 3 percent",
"     </li>",
"     <li>",
"      Hemoglobin A (two alpha chains and two beta chains) &mdash; 95 to 98 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The most commonly seen abnormal hemoglobins (eg, hemoglobins S and C) will be present as an additional electrophoretic band separate from hemoglobin A, with HbC having the slowest and HbA the fastest migration when electrophoresis is performed at an alkaline pH of 8.6 to 8.8 (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef68806 \" href=\"UTD.htm?8/51/9023\">",
"     image 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In the most simple of cases, heterozygotes will have 35 to 55 percent of the abnormal hemoglobin band with the remainder being HbA, compound heterozygotes (ie, hemoglobin SC disease) will have two approximately equal mutant bands with no HbA, and homozygotes will have only a single mutant hemoglobin band and no HbA (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef68806 \" href=\"UTD.htm?8/51/9023\">",
"     image 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In more complex situations (eg, the presence of a concomitant thalassemic mutation) or when the abnormal hemoglobin has an electrophoretic migration pattern similar to that of HbA, HbS, or HbC at an alkaline pH, electrophoresis may have to be run at an acid pH, or more extensive molecular studies may be required. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/60/968?source=see_link\">",
"     \"Laboratory diagnosis of the hemoglobinopathies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Hemoglobin S",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemoglobin (Hb)S, caused by a mutation of the beta globin chain, causes morbidity by its propensity, when deoxygenated, to aggregate into rigid polymers, cause the formation of sickle-shaped red cells (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef77366 \" href=\"UTD.htm?43/18/44335\">",
"     image 2",
"    </a>",
"    ), and to occlude flow in the microcirculation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/25/30104?source=see_link\">",
"     \"Sickle hemoglobin polymer: Structure and functional properties\"",
"    </a>",
"    .) It is frequent in Africa, the Middle East, Mediterranean countries and among the tribes of India. It is also found in other locations to which these populations have migrated.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sickle cell trait, or heterozygosity for hemoglobins A and S (HbAS), is present in 8 to 10 percent of African-Americans and in a small percent of those of Hispanic origin. It is a benign carrier condition with no hematologic manifestations. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/40/13960?source=see_link\">",
"       \"Sickle cell trait\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Combined heterozygosity for hemoglobins S and C (HbSC disease) is one of the symptomatic variant sickle cell syndromes. It is generally less severe than homozygous sickle cell disease (HbSS). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/5/5209?source=see_link&amp;anchor=H2#H2\">",
"       \"Variant sickle cell syndromes\", section on 'Hb SC disease'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Homozygosity for hemoglobin S (HbSS) is the condition generally known as sickle cell anemia or sickle cell disease. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/54/42856?source=see_link&amp;anchor=H12#H12\">",
"       \"Diagnosis of sickle cell syndromes\", section on 'Findings in sickle cell disease'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Hemoglobin E",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemoglobin E (HbE), a mutation of the beta globin chain, is associated with reduced expression (ie, it is a hemoglobin mutation which also expresses a thalassemic blood picture) and is mildly unstable to oxidative damage [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16984/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. The presence of HbE causes few abnormalities other than microcytosis, target cells, and hypochromia when present in a heterozygous or homozygous state [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16984/abstract/22\">",
"     22",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Heterozygotes (hemoglobin E trait) are not usually anemic, but may have minimal degrees of microcytosis and hypochromia. Hemoglobin electrophoresis shows approximately 30 percent HbE, 1 percent HbF, and 70 percent HbA.",
"     </li>",
"     <li>",
"      Homozygotes (hemoglobin E disease) have minimal anemia along with hypochromia, target cells, and prominent microcytosis. Hemoglobin electrophoresis shows &gt;90 percent HbE and no Hb A, with the remainder being HbF.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This mutation is very frequent in the Indian subcontinent and southeast Asia, where the frequency of HbE approaches 60 percent, presumably because of the resistance of Hb AE red cells to invasion by P. falciparum. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/23/20858?source=see_link&amp;anchor=H15#H15\">",
"     \"Protection against malaria in the hemoglobinopathies\", section on 'Hemoglobin E'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    HbE has an electrophoretic mobility similar to that of HbC on alkaline electrophoresis. It can be distinguished from HbC as it has the same migration at acid pH as HbA. It can be distinguished from HbO-Arab, which migrates closer to HbS on acid pH, or by HPLC methods [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16984/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A variable and occasionally much more severe phenotype is seen when this mutation is combined with one of two other beta globin chain mutations (ie, sickle cell or beta thalassemia). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/5/5209?source=see_link&amp;anchor=H14#H14\">",
"     \"Variant sickle cell syndromes\", section on 'Sickle-Hb E disease'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/58/9129?source=see_link&amp;anchor=H23#H23\">",
"     \"Molecular pathology of the thalassemic syndromes\", section on 'Hb E: A special case'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Hemoglobin C",
"    </span>",
"    &nbsp;&mdash;&nbsp;HbC, a beta globin chain mutation, is less soluble than HbA, forming hexagonal crystals (",
"    <a class=\"graphic graphic_picture graphicRef61082 \" href=\"UTD.htm?5/48/5892\">",
"     picture 1",
"    </a>",
"    ) rather than the long polymers seen in sickle cell disease (",
"    <a class=\"graphic graphic_picture graphicRef64449 \" href=\"UTD.htm?1/42/1703\">",
"     picture 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16984/abstract/24\">",
"     24",
"    </a>",
"    ]. More importantly, HbC, either in the homozygous state (HbCC) or in heterozygous states (HbSC, HbAC) induces red cell dehydration [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16984/abstract/16,25,26\">",
"     16,25,26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/15/14583?source=see_link&amp;anchor=H10#H10\">",
"     \"Xerocytosis\", section on 'Hemoglobin C disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with hemoglobin C trait (HbAC) are phenotypically normal, while those with hemoglobin C disease (HbCC) have a mild degree of hemolysis with splenomegaly, and are minimally anemic. In addition to the presence of crystals, target cells are numerous on the peripheral smear of patients with homozygous HbCC (",
"    <a class=\"graphic graphic_picture graphicRef61082 \" href=\"UTD.htm?5/48/5892\">",
"     picture 1",
"    </a>",
"    ). This mutation is frequent in Atlantic West Africa and in geographical areas to which these populations have migrated. The presence of this mutation does not protect against uncomplicated malaria, but may protect against the more severe forms [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16984/abstract/27\">",
"     27",
"    </a>",
"    ]. Patients with HbCC do not experience sickling events. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/23/20858?source=see_link\">",
"     \"Protection against malaria in the hemoglobinopathies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Hemoglobin D",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common HbD variant, HbD-Los Angeles (beta 121 Glu-&gt;Gln, also called HbD-Punjab), is caused by a glutamic acid to glutamine substitution at codon 121 of the beta globin gene [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16984/abstract/5\">",
"     5",
"    </a>",
"    ]. HbD-Los Angeles has an electrophoretic mobility similar to HbS at alkaline pH. It can be distinguished from HbS by the fact that it has the same migration at acid pH as HbA and does not undergo the sickling phenomenon in vitro.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Subjects with HbD trait are asymptomatic, not anemic, and have normal red cell indices.",
"     </li>",
"     <li>",
"      Homozygosity for HbD (hemoglobin D disease) is rare and is associated with only mild laboratory abnormalities [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16984/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Inheritance of HbD together with HbS (ie, HbSD disease) can result in a severe disease with clinical manifestations similar to homozygous sickle cell disease. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/5/5209?source=see_link&amp;anchor=H12#H12\">",
"       \"Variant sickle cell syndromes\", section on 'Sickle-Hb D disease'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Hemoglobin H",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemoglobin H is composed of a tetramer of normal beta chains (ie, beta-4), and is seen in inherited or acquired thalassemic settings in which there is markedly decreased production of normal alpha chains. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/13/38106?source=see_link&amp;anchor=H33#H33\">",
"     \"Clinical manifestations and diagnosis of the thalassemias\", section on 'Hemoglobin H disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hemoglobin H is a fast-moving hemoglobin, with a mobility at alkaline pH significantly faster than that of hemoglobin A (",
"    <a class=\"graphic graphic_figure graphicRef50325 \" href=\"UTD.htm?7/33/7711\">",
"     figure 2",
"    </a>",
"    ) and a tendency to form multiple small inclusions when the red cells are incubated in the presence of a redox dye such as brilliant cresyl blue (",
"    <a class=\"graphic graphic_picture graphicRef77536 \" href=\"UTD.htm?14/49/15123\">",
"     picture 3",
"    </a>",
"    ). If the presence of hemoglobin H is suspected, it is reasonable to reduce the length of time that electrophoresis is carried out, in order to prevent hemoglobin H, if present, to completely run off the gel and be considered absent.",
"   </p>",
"   <p>",
"    There are two inherited syndromes associated with the presence of hemoglobin H",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hemoglobin H disease, a form of alpha thalassemia with only one alpha chain gene (out of a potential total of four) being functional",
"      <span class=\"nowrap\">",
"       (a-/--).",
"      </span>",
"      Hemoglobin H comprises 5 to 30 percent of total hemoglobin in this condition.",
"     </li>",
"     <li>",
"      Nonimmune hydrops fetalis due to alpha thalassemia major, a genetic condition with no functional alpha chains (eg",
"      <span class=\"nowrap\">",
"       --/--).",
"      </span>",
"      Hemoglobin H comprises only a small percent of total hemoglobin in this condition, since only small amounts of beta chains are produced at the time of birth. The majority of hemoglobin is Bart's (gamma-4 tetramers). This condition is incompatible with extrauterine life, as all of the functional hemoglobins produced in the newborn (ie, hemoglobins F, A, and A2) contain alpha chains. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/37/34393?source=see_link&amp;anchor=H19#H19\">",
"       \"Nonimmune hydrops fetalis\", section on 'Anemia'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Acquired hemoglobin H disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemoglobin H disease (also called acquired alpha thalassemia) may be seen in an acquired setting in patients with myelodysplastic syndrome or in other hematologic malignancies (",
"    <a class=\"graphic graphic_figure graphicRef50325 \" href=\"UTD.htm?7/33/7711\">",
"     figure 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef77536 \" href=\"UTD.htm?14/49/15123\">",
"     picture 3",
"    </a>",
"    ). An acquired somatic mutation of ATRX, an X-linked gene encoding a chromatin-associated protein, has been linked to this entity. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/58/9129?source=see_link&amp;anchor=H5#H5\">",
"     \"Molecular pathology of the thalassemic syndromes\", section on 'ATRX mutations and alpha thalassemia'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/57/41882?source=see_link&amp;anchor=H4008672#H4008672\">",
"     \"Clinical manifestations and diagnosis of the myelodysplastic syndromes\", section on 'Acquired hemoglobin H disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Infrequent hemoglobin mutations",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Unstable hemoglobins",
"    </span>",
"    &nbsp;&mdash;&nbsp;The unstable hemoglobin mutants (eg, Hb Koln) are also relatively insoluble. Rather than forming ordered polymers or crystals, these mutant molecules aggregate into amorphous precipitates (Heinz bodies) (",
"    <a class=\"graphic graphic_picture graphicRef73790 \" href=\"UTD.htm?25/28/26054\">",
"     picture 4",
"    </a>",
"    ), which cause hemolysis because of damage to the red cell membrane and consequent impairment of red cell deformability. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/38/616?source=see_link\">",
"     \"Unstable hemoglobin variants\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     High oxygen affinity hemoglobins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemoglobin mutants with abnormally high oxygen affinity (",
"    <a class=\"graphic graphic_figure graphicRef81216 \" href=\"UTD.htm?2/26/2479\">",
"     figure 3",
"    </a>",
"    ) are associated with secondary erythrocytosis (eg, Hb Chesapeake), due to impaired oxygen delivery to tissues. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/4/42055?source=see_link&amp;anchor=H5#H5\">",
"     \"Genetic disorders of hemoglobin oxygen affinity\", section on 'High oxygen affinity hemoglobins: Erythrocytosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/17/29978?source=see_link&amp;anchor=H14#H14\">",
"     \"Molecular pathogenesis of congenital polycythemic disorders and polycythemia vera\", section on 'High oxygen affinity hemoglobin mutants'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Low oxygen affinity hemoglobins",
"    </span>",
"    &nbsp;&mdash;&nbsp;The much less common low affinity hemoglobin mutants (eg, Hb Kansas) are sometimes so unsaturated with oxygen that they may cause visible cyanosis (",
"    <a class=\"graphic graphic_figure graphicRef81216 \" href=\"UTD.htm?2/26/2479\">",
"     figure 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/4/42055?source=see_link&amp;anchor=H18#H18\">",
"     \"Genetic disorders of hemoglobin oxygen affinity\", section on 'Low oxygen affinity hemoglobin mutants: Cyanosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Hemoglobin M disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with one of the M (methemoglobin) hemoglobins, in which the heme iron is locked in the ferric or methemoglobin form, may also present with cyanosis, caused by increased concentrations of methemoglobin. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/46/4841?source=see_link&amp;anchor=H22#H22\">",
"     \"Genetics and pathogenesis of methemoglobinemia\", section on 'Hemoglobin M disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Hemoglobin Lepore",
"    </span>",
"    &nbsp;&mdash;&nbsp;HbLepore arises from an unequal crossing over and recombination event between adjacent delta and beta globin genes. The fused globin forms a functional and stable hemoglobin with the mobility of HbS on alkaline electrophoresis and HbA on acid electrophoresis. HbLepore does not undergo the sickling phenomenon, but may be confused with HbS as it migrates to the same position as HbS on alkaline electrophoresis (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef68806 \" href=\"UTD.htm?8/51/9023\">",
"     image 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Because the production of the abnormal globin is under the control of the delta globin promoter, which is only 2 to 3 percent as active as the beta globin promoter, there is severe underproduction of this abnormal globin chain, such that HbLepore represents only about 3 to 20 percent of total hemoglobin in the affected subject, rather than the expected level of approximately 50 percent. Since no functional delta chain can be produced by the abnormal chromosome, the concentration of hemoglobin A2 is decreased to about 50 percent of normal. Hemoglobin F levels are usually slightly increased.",
"   </p>",
"   <p>",
"    Unbalanced production of alpha and beta-like globin results, producing thalassemia of moderate-to-high severity in homozygotes and a mild beta thalassemia minor-like picture in heterozygotes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/58/9129?source=see_link&amp;anchor=H15#H15\">",
"     \"Molecular pathology of the thalassemic syndromes\", section on 'Hb Lepore'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15458746\">",
"    <span class=\"h3\">",
"     Hemoglobin Constant Spring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemoglobin Constant Spring is a structural variant associated with alpha thalassemia in Asia. It is associated with the presence of a minor, very slowly migrating abnormal hemoglobin component on electrophoresis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/13/38106?source=see_link&amp;anchor=H38#H38\">",
"     \"Clinical manifestations and diagnosis of the thalassemias\", section on 'Hemoglobin Constant Spring'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Hemoglobin O-Arab",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemoglobin O-Arab, a beta chain hemoglobin mutation (beta 121 Glu-&gt;Lys), was first described in an Israeli Arab family but its distribution is widespread. Heterozygotes are clinically asymptomatic with no hematologic abnormalities, while those homozygous for HbO-Arab may have a mild, asymptomatic, compensated hemolytic anemia [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16984/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hemoglobin O-Arab is of clinical significance when coinherited with HbS. Such subjects have clinical and laboratory abnormalities as severe as those with homozygous sickle cell disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/5/5209?source=see_link&amp;anchor=H13#H13\">",
"     \"Variant sickle cell syndromes\", section on 'Sickle-Hb O Arab disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    HbO-Arab migrates with the same mobility as HbC on alkaline electrophoresis, and has a migration pattern intermediate between that of HbA and HbS on acid electrophoresis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16984/abstract/23\">",
"     23",
"    </a>",
"    ]. HbO-Arab can also be distinguished from HbC or HbE through the use of HPLC.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     HEMOGLOBIN GENE DATABASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;A database of known mutations of the human hemoglobin gene is kept by the Globin Gene Server [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16984/abstract/1,29\">",
"     1,29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1938444\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Over 800 different mutations of the globin chains of the human hemoglobin molecule have been discovered. They are classified according to the type of mutation (eg, insertion, deletion, base change), the affected globin subunit (eg, alpha chain, beta chain), and by the clinical and hematologic phenotype (eg, altered solubility, stability, oxygen affinity, or synthesis) (",
"    <a class=\"graphic graphic_table graphicRef61649 \" href=\"UTD.htm?17/10/17579\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef62517 \" href=\"UTD.htm?8/43/8892\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Infrequent hemoglobin mutations'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    While the majority of hemoglobin mutants are not associated with any clinical manifestations and are found in less than 1 percent of the population, some are quite common (eg, hemoglobins S, C, and E) and are the product of expansion via selective",
"    <strong>",
"     external",
"    </strong>",
"    forces (eg, malaria) because, in the asymptomatic heterozygous form, they protect carriers from dying of malarial infection. These latter mutations are ethnic-specific, in that they are present in some human populations and not in others. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Incidence'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1938565\">",
"    <span class=\"h2\">",
"     The normal hemoglobins",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the normal adult, three different hemoglobins are found on hemoglobin electrophoresis: hemoglobins A (adult), A2, and F (fetal). They are found in the following amounts (",
"    <a class=\"graphic graphic_table graphicRef64715 \" href=\"UTD.htm?17/56/18316\">",
"     table 3",
"    </a>",
"    ) (see",
"    <a class=\"local\" href=\"#H8\">",
"     'Normal hemoglobin electrophoretic pattern'",
"    </a>",
"    above):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Hemoglobin F &mdash; less than 1 percent",
"     </li>",
"     <li>",
"      Hemoglobin A2 &mdash; 2 to 3 percent",
"     </li>",
"     <li>",
"      Hemoglobin A &mdash; 95 to 98 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1938627\">",
"    <span class=\"h2\">",
"     The abnormal hemoglobins",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, individuals who are heterozygous for an abnormal hemoglobin will have 35 to 55 percent of the abnormal hemoglobin with the remainder being HbA; compound heterozygotes (ie, hemoglobin SC disease) will have two approximately equal mutant bands with no HbA; and homozygotes will have only a single mutant hemoglobin band and no HbA (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef68806 \" href=\"UTD.htm?8/51/9023\">",
"     image 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In more complex settings (eg, when there is concomitant alpha thalassemia), the proportion of the abnormal hemoglobin in heterozygotes may be more or less than that quoted above (ie, 35 to 55 percent), depending on a number of factors, such as the number of functioning genes in the individual, stability of the messenger RNA, rate of synthesis and stability of the gene product, and the efficiency with which the abnormal hemoglobin is assembled. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Quantitation of mutant hemoglobins'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1938717\">",
"    <span class=\"h3\">",
"     Hemoglobin S syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individuals who have inherited hemoglobin S from one or both parents may have a number of different phenotypes, including the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Sickle cell trait",
"      </strong>",
"      , or heterozygosity for hemoglobins A and S (HbAS) is a benign carrier condition with no hematologic manifestations. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/40/13960?source=see_link\">",
"       \"Sickle cell trait\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Combined heterozygosity for hemoglobins S and C",
"      </strong>",
"      (HbSC disease) is one of the symptomatic variant sickle cell syndromes. It is generally less severe than homozygous sickle cell disease (HbSS). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/5/5209?source=see_link&amp;anchor=H2#H2\">",
"       \"Variant sickle cell syndromes\", section on 'Hb SC disease'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Homozygosity for hemoglobin S",
"      </strong>",
"      (HbSS) is the condition generally known as sickle cell anemia or sickle cell disease. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/54/42856?source=see_link&amp;anchor=H12#H12\">",
"       \"Diagnosis of sickle cell syndromes\", section on 'Findings in sickle cell disease'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1939303\">",
"    <span class=\"h3\">",
"     Hemoglobin H syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are three syndromes (two inherited and one acquired) associated with the presence of hemoglobin H, a tetramer comprised of four normal beta chains. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Hemoglobin H'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Hemoglobin H disease",
"      </strong>",
"      is a form of severe alpha thalassemia in which only one alpha chain gene (out of a potential total of four) is functional (ie,",
"      <span class=\"nowrap\">",
"       a-/--).",
"      </span>",
"      Hemoglobin H comprises 5 to 30 percent of total hemoglobin in this condition.",
"     </li>",
"     <li>",
"      <strong>",
"       Alpha thalassemia major",
"      </strong>",
"      (nonimmune hydrops fetalis) is the most severe form of alpha thalassemia, in which there are no functional alpha chains (ie,",
"      <span class=\"nowrap\">",
"       --/--).",
"      </span>",
"      Hemoglobin H comprises only a small percent of total hemoglobin in this condition, with the majority being hemoglobin Bart's. This condition is incompatible with extrauterine life, as all of the functional hemoglobins produced in the newborn (ie, hemoglobins F, A, and A2) contain alpha chains. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/37/34393?source=see_link&amp;anchor=H19#H19\">",
"       \"Nonimmune hydrops fetalis\", section on 'Anemia'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Acquired hemoglobin H disease",
"      </strong>",
"      (acquired alpha thalassemia) may be seen in patients with myelodysplastic syndrome or in other hematologic malignancies.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16984/abstract/1\">",
"      Hardison RC, Chui DH, Riemer C, et al. Databases of human hemoglobin variants and other resources at the globin gene server. Hemoglobin 2001; 25:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16984/abstract/2\">",
"      Weatherall DJ. The inherited diseases of hemoglobin are an emerging global health burden. Blood 2010; 115:4331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16984/abstract/3\">",
"      Wilson JB, Chen SS, Webber BB, et al. The identification of five rare beta-chain abnormal hemoglobins by high performance liquid chromatographic procedures. Hemoglobin 1986; 10:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16984/abstract/4\">",
"      Lubin BH, Witkowska HE, Kleman K. Laboratory diagnosis of hemoglobinopathies. Clin Biochem 1991; 24:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16984/abstract/5\">",
"      Schnee J, Aulehla-Scholz C, Eigel A, Horst J. Hb D Los Angeles (D-Punjab) and Hb Presbyterian: analysis of the defect at the DNA level. Hum Genet 1990; 84:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16984/abstract/6\">",
"      Codrington JF, Kutlar F, Harris HF, et al. Hb A2-Wrens or alpha 2 delta 2 98(FG5) Val----Met, an unstable delta chain variant identified by sequence analysis of amplified DNA. Biochim Biophys Acta 1989; 1009:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16984/abstract/7\">",
"      Camaschella C, Saglio G. Recent advances in diagnosis of hemoglobinopathies. Crit Rev Oncol Hematol 1993; 14:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16984/abstract/8\">",
"      Cash FE, Monplaisir N, Goossens M, Liebhaber SA. Locus assignment of two alpha-globin structural mutants from the Caribbean basin: alpha Fort de France (alpha 45 Arg) and alpha Spanish Town (alpha 27 Val). Blood 1989; 74:833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16984/abstract/9\">",
"      Bunn HF, McDonald MJ. Electrostatic interactions in the assembly of haemoglobin. Nature 1983; 306:498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16984/abstract/10\">",
"      Bunn HF. Subunit assembly of hemoglobin: an important determinant of hematologic phenotype. Blood 1987; 69:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16984/abstract/11\">",
"      Liebhaber SA, Cash FE, Cornfield DB. Evidence for posttranslational control of Hb C synthesis in an individual with Hb C trait and alpha-thalassemia. Blood 1988; 71:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16984/abstract/12\">",
"      Huisman TH. Percentages of abnormal hemoglobins in adults with a heterozygosity for an alpha-chain and/or a beta-chain variant. Am J Hematol 1983; 14:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16984/abstract/13\">",
"      Steinberg MH, Embury SH. Alpha-thalassemia in blacks: genetic and clinical aspects and interactions with the sickle hemoglobin gene. Blood 1986; 68:985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16984/abstract/14\">",
"      Mrabet NT, McDonald MJ, Turci S, et al. Electrostatic attraction governs the dimer assembly of human hemoglobin. J Biol Chem 1986; 261:5222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16984/abstract/15\">",
"      Adachi K, Yamaguchi T, Pang J, Surrey S. Effects of increased anionic charge in the beta-globin chain on assembly of hemoglobin in vitro. Blood 1998; 91:1438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16984/abstract/16\">",
"      Bunn HF, Noguchi CT, Hofrichter J, et al. Molecular and cellular pathogenesis of hemoglobin SC disease. Proc Natl Acad Sci U S A 1982; 79:7527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16984/abstract/17\">",
"      Huisman TH. Trimodality in the percentages of beta chain variants in heterozygotes: the effect of the number of active Hbalpha structural loci. Hemoglobin 1977; 1:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16984/abstract/18\">",
"      Adams JG 3rd, Coleman MB, Hayes J, et al. Modulation of fetal hemoglobin synthesis by iron deficiency. N Engl J Med 1985; 313:1402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16984/abstract/19\">",
"      Chui DH, Patterson M, Dowling CE, et al. Hemoglobin Bart's disease in an Italian boy. Interaction between alpha-thalassemia and hereditary persistence of fetal hemoglobin. N Engl J Med 1990; 323:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16984/abstract/20\">",
"      Macdonald VW, Charache S. Differences in the reaction sequences associated with drug-induced oxidation of hemoglobins E, S, A, and F. J Lab Clin Med 1983; 102:762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16984/abstract/21\">",
"      Lachant NA, Tanaka KR. Dapsone-associated Heinz body hemolytic anemia in a Cambodian woman with hemoglobin E trait. Am J Med Sci 1987; 294:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16984/abstract/22\">",
"      Vichinsky E. Hemoglobin e syndromes. Hematology Am Soc Hematol Educ Program 2007; :79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16984/abstract/23\">",
"      Joutovsky A, Nardi M. Hemoglobin C and hemoglobin O-Arab variants can be diagnosed using the Bio-Rad Variant II high-performance liquid chromatography system without further confirmatory tests. Arch Pathol Lab Med 2004; 128:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16984/abstract/24\">",
"      Hirsch RE, Raventos-Suarez C, Olson JA, Nagel RL. Ligand state of intraerythrocytic circulating HbC crystals in homozygote CC patients. Blood 1985; 66:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16984/abstract/25\">",
"      Fabry ME, Kaul DK, Raventos-Suarez C, et al. SC erythrocytes have an abnormally high intracellular hemoglobin concentration. Pathophysiological consequences. J Clin Invest 1982; 70:1315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16984/abstract/26\">",
"      Brugnara C, Kopin AS, Bunn HF, Tosteson DC. Regulation of cation content and cell volume in hemoglobin erythrocytes from patients with homozygous hemoglobin C disease. J Clin Invest 1985; 75:1608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16984/abstract/27\">",
"      Agarwal A, Guindo A, Cissoko Y, et al. Hemoglobin C associated with protection from severe malaria in the Dogon of Mali, a West African population with a low prevalence of hemoglobin S. Blood 2000; 96:2358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16984/abstract/28\">",
"      Adekile AD, Kazanetz EG, Leonova JY, et al. Co-inheritance of Hb D-Punjab (codon 121; GAA--&gt;CAA) and beta (0) -thalassemia (IVS-II-1;G--&gt;A). J Pediatr Hematol Oncol 1996; 18:151.",
"     </a>",
"    </li>",
"    <li>",
"     The Globin Gene Server is available at file://globin.cse.psu.edu/ (Accessed on January 31, 2007).",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7127 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-217.117.136.88-353D9881C8-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_37_16984=[""].join("\n");
var outline_f16_37_16984=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H1938444\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INCIDENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      QUANTITATION OF MUTANT HEMOGLOBINS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Assembly of the mutant hemoglobin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Positively charged beta chain mutants",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Negatively charged beta chain mutants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      CLINICAL PHENOTYPES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Normal hemoglobin electrophoretic pattern",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Hemoglobin S",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Hemoglobin E",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Hemoglobin C",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Hemoglobin D",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Hemoglobin H",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Acquired hemoglobin H disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Infrequent hemoglobin mutations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Unstable hemoglobins",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - High oxygen affinity hemoglobins",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Low oxygen affinity hemoglobins",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Hemoglobin M disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Hemoglobin Lepore",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15458746\">",
"      - Hemoglobin Constant Spring",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Hemoglobin O-Arab",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      HEMOGLOBIN GENE DATABASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1938444\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1938565\">",
"      The normal hemoglobins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1938627\">",
"      The abnormal hemoglobins",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1938717\">",
"      - Hemoglobin S syndromes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1939303\">",
"      - Hemoglobin H syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/7127\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7127|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?8/51/9023\" title=\"diagnostic image 1\">",
"      Hemoglobin electrophoresis at alkaline pH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?43/18/44335\" title=\"diagnostic image 2\">",
"      Sickle cell scanning EM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7127|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?0/58/942\" title=\"figure 1\">",
"      Effect of globin charge on hemoglobin assembly",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?7/33/7711\" title=\"figure 2\">",
"      Electrophoresis hgb H",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/26/2479\" title=\"figure 3\">",
"      Hemoglobin oxygen dissociation curve",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7127|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?5/48/5892\" title=\"picture 1\">",
"      Hemoglobin C disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?1/42/1703\" title=\"picture 2\">",
"      Sickle cell anemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/49/15123\" title=\"picture 3\">",
"      Hgb H inclusions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?25/28/26054\" title=\"picture 4\">",
"      Heinz body hemolytic anemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7127|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/10/17579\" title=\"table 1\">",
"      Hemoglobin mutation syndromes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?8/43/8892\" title=\"table 2\">",
"      Mechanisms of globin mutations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/56/18316\" title=\"table 3\">",
"      Hgb electrophoresis patterns",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/17/16667\" title=\"table 4\">",
"      Sickle trait alpha thalassemia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/57/41882?source=related_link\">",
"      Clinical manifestations and diagnosis of the myelodysplastic syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/13/38106?source=related_link\">",
"      Clinical manifestations and diagnosis of the thalassemias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/51/41783?source=related_link\">",
"      Community public health issues and the thalassemic syndromes: Lessons from other countries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/54/42856?source=related_link\">",
"      Diagnosis of sickle cell syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/4/42055?source=related_link\">",
"      Genetic disorders of hemoglobin oxygen affinity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/46/4841?source=related_link\">",
"      Genetics and pathogenesis of methemoglobinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/60/968?source=related_link\">",
"      Laboratory diagnosis of the hemoglobinopathies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/17/29978?source=related_link\">",
"      Molecular pathogenesis of congenital polycythemic disorders and polycythemia vera",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/58/9129?source=related_link\">",
"      Molecular pathology of the thalassemic syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/37/34393?source=related_link\">",
"      Nonimmune hydrops fetalis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/11/36025?source=related_link\">",
"      Pathophysiology of alpha thalassemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/23/20858?source=related_link\">",
"      Protection against malaria in the hemoglobinopathies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/40/13960?source=related_link\">",
"      Sickle cell trait",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/25/30104?source=related_link\">",
"      Sickle hemoglobin polymer: Structure and functional properties",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/29/23001?source=related_link\">",
"      Structure and function of normal human hemoglobins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/38/616?source=related_link\">",
"      Unstable hemoglobin variants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/5/5209?source=related_link\">",
"      Variant sickle cell syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/15/14583?source=related_link\">",
"      Xerocytosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_37_16985="Acetabular fracture general classification";
var content_f16_37_16985=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F57299&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F57299&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Letournel and Judet classification for acetabular fractures",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 337px; height: 684px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Moed BR, Reilly MC. Lower extremity: Acetabulum fractures. In: Rockwood and Green's Fractures in Adults, vol 2, 7th ed, Bucholz RW, Court-Brown CM, Heckman JD, Tornetta P (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2010. Copyright &copy; 2010 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_37_16985=[""].join("\n");
var outline_f16_37_16985=null;
var title_f16_37_16986="An overview of the innate immune system";
var content_f16_37_16986=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   An overview of the innate immune system",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/37/16986/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/37/16986/contributors\">",
"     Richard B Johnston, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/37/16986/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/37/16986/contributors\">",
"     E Richard Stiehm, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/37/16986/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/37/16986/contributors\">",
"     Anna M Feldweg, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/37/16986/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H9420958\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Humans exist in an environment teeming with microorganisms, and we could not have survived as a species without effective mechanisms to prevent and respond to microbial invasion. The human innate immune system consists of genetically programmed (germline) defense mechanisms that are directed against molecular components found only in microorganisms. Humans share these defense mechanisms, as conserved elements or homologs, with other vertebrates and some insects and plants in a beautiful expression of the process of evolution [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    &ldquo;Innate&rdquo; immunity refers to immune responses that are present from birth and not learned, adapted, or permanently heightened as a result of exposure to microorganisms, in contrast to the responses of T and B lymphocytes in the adaptive immune system. The importance of this innate system is emphasized by the fact that the generation time of most bacteria is 20 to 30 minutes, whereas the development of a specific adaptive response takes days to weeks. The cardinal signs of inflammation: tumor, rubor, calor, and dolor (swelling, redness, heat, and pain), are products of the innate immune response.",
"   </p>",
"   <p>",
"    The cells, proteins, and receptors that comprise the innate immune system and the conceptual and functional differences between innate and acquired immune responses will be reviewed here. Defects in the innate immune system that illustrate biologic activities of innate immune constituents will be briefly discussed. Interactions between innate and acquired immune mechanisms, disorders of innate immunity, and more detailed reviews of specific aspects of the innate immune system are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/54/23401?source=see_link\">",
"     \"Toll-like receptors: Roles in disease and therapy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/59/11190?source=see_link\">",
"     \"Complement pathways\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/8/12420?source=see_link\">",
"     \"Mannose-binding lectin\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/22/44393?source=see_link\">",
"     \"Mast cells: Development, identification, and physiologic roles\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23899400\">",
"    <span class=\"h1\">",
"     COMPONENTS AND FUNCTIONS OF THE INNATE IMMUNE SYSTEM",
"    </span>",
"    &nbsp;&mdash;&nbsp;A diversity of components makes up the innate immune system, including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Physical barriers (tight junctions in the skin, epithelial and mucous membrane surfaces, mucus itself)",
"     </li>",
"     <li>",
"      Epithelial and phagocytic cell enzymes (eg, lysozyme)",
"     </li>",
"     <li>",
"      Phagocytes (neutrophils, monocytes, macrophages)",
"     </li>",
"     <li>",
"      Inflammation-related serum proteins (eg, complement, C-reactive protein, lectins such as mannose-binding lectin and ficolins)",
"     </li>",
"     <li>",
"      Surface and phagocyte granule antimicrobial peptides (defensins, cathelicidin, and many more)",
"     </li>",
"     <li>",
"      Cell receptors that sense microorganisms and signal a defensive response (eg, Toll-like receptors)",
"     </li>",
"     <li>",
"      Cells that release cytokines and inflammatory mediators (macrophages, mast cells, natural-killer cells)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The innate immune system has several critical functions:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Detection of microorganisms and first-line defense against invasion and infection. (See",
"      <a class=\"local\" href=\"#H9420986\">",
"       'Microbial detection through pattern recognition'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Activation and instruction of adaptive immune responses.",
"     </li>",
"     <li>",
"      Regulation of inflammation.",
"     </li>",
"     <li>",
"      Maintenance of &ldquo;immunologic homeostasis&rdquo; within the host.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9420979\">",
"    <span class=\"h1\">",
"     INNATE VERSUS ADAPTIVE IMMUNITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mechanisms by which the innate and adaptive (acquired) immune systems function are fundamentally different:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The innate immune system recognizes microbes through pattern recognition receptors (PRRs), which are receptors specific for molecular components of microorganisms that are not made by the host. Some innate immune responses are temporarily upregulated as a result of exposure to microbes, but the components of the innate immune system do not change permanently during an individual&rsquo;s lifetime. However, phylogenetic studies have indicated that genes for PRRs and other components have been gradually modified over generations by natural selection [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In contrast, adaptive immune responses are continually refined and adjusted throughout the lifetime of the host. Each T and B lymphocyte acquires a structurally unique receptor during development, yielding a vast repertoire of unique receptors. From this repertoire, cells exposed to microbial or other antigens are selected for clonal expansion, followed by changes that focus specificity and increase affinity. Thus, the most useful receptors are selected and improved in the host over time. However, the &ldquo;learned&rdquo; immune responses and refinements made to the adaptive system cannot be passed on to an individual&rsquo;s progeny. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/58/6056?source=see_link\">",
"       \"The adaptive cellular immune response\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27624?source=see_link\">",
"       \"The humoral immune response\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is important to note that the innate and adaptive immune systems interact supportively with each other.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9420986\">",
"    <span class=\"h1\">",
"     MICROBIAL DETECTION THROUGH PATTERN RECOGNITION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9420994\">",
"    <span class=\"h2\">",
"     Pattern recognition in innate immunity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Innate immune responses are largely mediated by a variety of proteins that recognize and interact with components that are specific to microbes. These proteins are grouped in their broad biologic context as &ldquo;pattern recognition receptors&rdquo; (PRRs) to emphasize their common function in host defense. The PRRs in this context can be divided into two broad groups: secreted and circulating proteins and peptides, and transmembrane and intracellular signal-transducing receptors (receptors in the more traditional sense). The list of PRRs and their ligands is expanding rapidly. Some of the best-studied molecules are discussed here.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Secreted and circulating pattern recognition molecules include antimicrobial peptides, lectins, collectins, and pentraxins. These proteins and peptides mediate direct microbial killing, act as helper proteins for transmembrane receptors, and act as opsonins for phagocytosis by innate and adaptive immune effector cells.",
"     </li>",
"     <li>",
"      Membrane-bound PRRs are expressed constitutively on many types of innate immune cells and on the professional antigen presenting cells (macrophages, dendritic cells, monocytes, and B lymphocytes). On all these cells, transmembrane signaling PRRs act as sentinels. Upon activation, they induce rapid up-regulation of other PRRs. The principal transmembrane and intracellular signal-transducing PRRs include the plasma membrane-bound and intracellular Toll-like receptors (TLRs) and their associated detection-enhancing proteins (LPS-binding protein, CD14, and MD2); nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs), termed NOD1 and 2; RIG-1-like receptors (RLRs), termed RIG-1, MDA5, and LPG2; and C-type lectin receptors (Dectins 1 and 2 and MINCLE on macrophages and dendritic cells) [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/3-8\">",
"       3-8",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9421001\">",
"    <span class=\"h2\">",
"     Pathogen-associated molecular patterns",
"    </span>",
"    &nbsp;&mdash;&nbsp;PRRs are capable of distinguishing between self tissues and a specific class of microbes by recognizing highly conserved pathogen-associated molecular patterns (PAMPs). Each type of PAMP is characteristic of a specific group of microbes.",
"   </p>",
"   <p>",
"    PAMP structures have certain features in common:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      PAMPs are produced only by microbes and not by their hosts.",
"     </li>",
"     <li>",
"      PAMPs are typically invariant structures shared by entire classes of pathogens.",
"     </li>",
"     <li>",
"      PAMP structures are usually fundamental to the integrity, survival, and pathogenicity of the microorganisms. The microbe cannot mutate its PAMPs to avoid the host&rsquo;s defense mechanisms and still survive.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A prototypical PAMP is bacterial endotoxin, or lipopolysaccharide (LPS), which is a component of the outer membrane of all gram-negative bacteria. Endotoxin contains Lipid A, a highly conserved structure of the lipid bilayer of the outer bacterial cell membrane that confers much of endotoxin's biological activities [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/9\">",
"     9",
"    </a>",
"    ]. Lipid A specifically interacts with the PRR toll-like receptor 4 (TLR4) (See",
"    <a class=\"local\" href=\"#H9421044\">",
"     'Toll-like receptors'",
"    </a>",
"    below.) Other examples of PAMPs include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Membrane components common to large categories of bacteria, such as peptidoglycan, lipoteichoic acids, and mannans",
"     </li>",
"     <li>",
"      Unmethylated microbial DNA",
"     </li>",
"     <li>",
"      Double-stranded RNA of viral origin",
"     </li>",
"     <li>",
"      Glucans, polysaccharides, or proteins that are common to microbes but not to animals or humans",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9421008\">",
"    <span class=\"h1\">",
"     PROTOTYPIC PRRs: SECRETED AND CIRCULATING",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9421016\">",
"    <span class=\"h2\">",
"     Antimicrobial peptides",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antimicrobial peptides (AMPs) are a group of secreted PRRs that are important in the protection of the skin and mucosal membranes and in the killing of phagocytosed organisms. AMPs secreted onto epithelial surfaces at a site of injury create a microbicidal shield that damages microorganisms prior to attachment and invasion. They are microbicidal against a broad range of bacteria, fungi, chlamydiae, and enveloped viruses [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/10-16\">",
"     10-16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    AMPs function by integrating into the outer cell membranes of microbes to form pores that disrupt membrane integrity and function. There is extensive diversity among AMPs, although all contain clusters of hydrophobic, cationic amino acids that bind to negatively charged phospholipids in the outer bilayer of bacterial membranes. The outer cell membranes of animals contain lipids that differ from those of microbes (including cholesterol), and AMPs are not attracted to them.",
"   </p>",
"   <p>",
"    Prototypic secreted and circulating PRRs include the following (",
"    <a class=\"graphic graphic_table graphicRef53389 \" href=\"UTD.htm?23/35/24124\">",
"     table 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Defensins, which are divided into alpha (&alpha;) and beta (&beta;) defensins:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Human &alpha; defensins (human neutrophil peptides 1 through 4) are azurophilic granule proteins of neutrophils and are also synthesized by Paneth cells at the base of small intestinal crypts (&alpha; defensins 5 and 6) [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/11,14\">",
"       11,14",
"      </a>",
"      ]. They comprise 2 to 4 percent of the cellular protein of neutrophils.",
"     </li>",
"     <li>",
"      Human &beta; defensins (HBDs) are expressed on all epithelial surfaces, including those of the airways, urinary and gastrointestinal tracts, mouth, cornea and conjunctivae, and skin. Their production by epithelial cells can be constitutive (as for HBD-1) or inducible (HBD-2, HBD-3, HBD-4). Infectious or traumatic injury of epithelium elicits inflammatory cytokines that induce defensin production [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/12,17,18\">",
"       12,17,18",
"      </a>",
"      ]. Defensins are short peptides (30 to 45 amino acids) that have three disulfide bonds that protect the peptide from protease degradation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The human cathelicidin, LL-37: This AMP is released from both neutrophils and epithelial cells and exhibits a broad range of antimicrobial activities [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/11\">",
"       11",
"      </a>",
"      ]. LL-37 is induced by vitamin D [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/19-21\">",
"       19-21",
"      </a>",
"      ]. In both keratinocytes and macrophages, stimulation of TLR2 results in the induction of the cytochrome P450 enzyme that converts vitamin D to the active form, which in turn induces the expression of the antimicrobial peptide LL-37. In this way, vitamin D can influence microbicidal defenses of both skin and circulating phagocytic cells [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/20\">",
"       20",
"      </a>",
"      ]. For this reason, certain human infections, such as Mycobacterium tuberculosis, may be more prevalent among populations with inadequate plasma levels of vitamin D, such as those with more deeply pigmented skin [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/21,22\">",
"       21,22",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/29/31193?source=see_link&amp;anchor=H651669#H651669\">",
"       \"Vitamin D and extraskeletal health\", section on 'Immune system'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    AMPs also serve as chemoattractants for innate immune cells, including neutrophils, and adaptive immune cells, thereby attracting an array of host defense cells to provide back-up support at the breached barrier. Human &alpha;-defensins attract immature dendritic cells and peripheral blood T cells, enhancing antigen-specific adaptive immune responses [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/23\">",
"     23",
"    </a>",
"    ]. Recruitment of dendritic cells by AMPs induces their maturation. The &beta;-defensins and LL-37 are chemoattractive for mast cells and can induce their degranulation [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/22/44393?source=see_link&amp;anchor=H14#H14\">",
"     \"Mast cells: Development, identification, and physiologic roles\", section on 'Innate immunity'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Epithelial and innate immune cells express multiple AMPs from several different structural classes, and they are expressed across the body. The existence of this broad repertoire of AMPs may in part explain the rarity of AMP resistance among pathogenic microbes. However, a second major function of these peptides is to govern the composition of the commensal microorganisms that colonize our body surfaces. These species, which lack the attributes of major pathogens, can be relatively resistant to AMPs and thus may have had an evolutionary advantage over other microbes in adapting to this niche [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Inherited variability in defensin gene expression may contribute to the risk of several diseases, including Crohn&rsquo;s disease and psoriasis, and solid research suggests that AMPs play a part in the pathophysiology of other diseases, such as atopic dermatitis and necrotizing enterocolitis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/12\">",
"     12",
"    </a>",
"    ]. Neutrophils and saliva in children with Kostmann&rsquo;s severe congenital neutropenia are deficient in defensins and LL-37. These children suffer life-threatening infections and severe periodontal disease.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/13/23767?source=see_link\">",
"     Granulocyte colony-stimulating factor",
"    </a>",
"    administration corrects the neutropenia but not the periodontitis. Bone marrow transplantation can restore salivary LL-37 to normal and allow control of the periodontal disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/22/24937?source=see_link&amp;anchor=H2#H2\">",
"     \"Congenital neutropenia\", section on 'Severe congenital neutropenia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9421023\">",
"    <span class=\"h2\">",
"     Collectins",
"    </span>",
"    &nbsp;&mdash;&nbsp;The collectins represent another type of secreted PRR (",
"    <a class=\"graphic graphic_table graphicRef53389 \" href=\"UTD.htm?23/35/24124\">",
"     table 1",
"    </a>",
"    ). Collectins are collagen-like proteins that bind to carbohydrate or lipid moieties in microbial cell walls. They can have direct microbicidal activity, flag the microbial cell for recognition by the complement system and phagocytosis, and promote uptake of proinflammatory apoptotic cells, particularly neutrophils [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/27-32\">",
"     27-32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mannose binding lectin (MBL) is an antimicrobial lectin, a well-characterized collectin, and an acute-phase reactant produced by the liver. MBL recognizes terminal mannose residues of carbohydrates on gram-positive and gram-negative bacteria, fungi, and some viruses and parasites. MBL can opsonize microbes for phagocytosis via the C1q receptor and activate the complement pathway, leading to microbial cell lysis, chemoattraction of neutrophils, and phagocytosis. MBL deficiency is associated with frequent infections in children or immunocompromised adults. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/8/12420?source=see_link\">",
"       \"Mannose-binding lectin\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/14/19690?source=see_link\">",
"       \"Mannose-binding lectin deficiency\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Two of the four pulmonary surfactant proteins (SP-A and SP-D) are collectins. These proteins bind oligosaccharide PAMPs found on a variety of microbes (gram-positive and gram-negative bacteria, viruses, fungi) [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/27-31\">",
"       27-31",
"      </a>",
"      ]. SP-A is expressed in the placental amnion and amniotic fluid where it may regulate the amniotic antiinflammatory response during pregnancy [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9421030\">",
"    <span class=\"h2\">",
"     Lectins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lectins are proteins that bind carbohydrates. In the context of host defense, they bind to microbial carbohydrates. MBL is the prototypic host defense lectin, but ficolins",
"    <span class=\"nowrap\">",
"     1/2/3",
"    </span>",
"    and galectins are other important host defense lectins [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/33-35\">",
"     33-35",
"    </a>",
"    ]. MBL and ficolins can bind directly to microbes and trigger antibody-independent activation of the lectin pathway, the third of the core pathways of complement activation (with the classical and alternative pathways). Fifteen members of the mammalian galectin family have been identified to date. Some of the human galectins can bind directly to bacteria, disrupt their membranes, and kill them in the absence of complement; and galectins can induce apoptosis of certain cells [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/36,37\">",
"     36,37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9421037\">",
"    <span class=\"h2\">",
"     Pentraxins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pentraxins are a large family of proteins, highly conserved through evolution and characterized by a C-terminal 200-amino acid pentraxin domain with five subunits [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/38-41\">",
"     38-41",
"    </a>",
"    ]. C-reactive protein (CRP) and serum amyloid P constitute the structurally short arm of the family; pentraxin-3 (PTX3) is the prototypic &ldquo;long pentraxin.&rdquo; All are acute phase reactants secreted in response to TLR activation or proinflammatory cytokines. CRP was the first PRR and the first pentraxin to be described. It is secreted by the liver and was named for its capacity to react with C-polysaccharide of pneumococci. It functions like an innate, rapidly responsive antibody in that it can fix C1q and activate the complement system, thereby opsonizing the organism to promote its phagocytic clearance. CRP also promotes phagocytosis by directly binding Fc-gamma receptors on phagocytes. PTX3 is secreted by a variety of tissues, particularly macrophages and dendritic cells. It can bind to endothelial P-selectin at sites of inflammation and decrease neutrophil recruitment, thereby acting to diminish inflammation as infection is controlled [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/41\">",
"     41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/42/38569?source=see_link&amp;anchor=H4#H4\">",
"     \"Acute phase reactants\", section on 'Role of CRP'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9421192\">",
"    <span class=\"h1\">",
"     PROTOTYPIC PRRs: CELL-ASSOCIATED",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cell associated PRRs include Toll like receptors (TLRs), PRRs linked to phagocytosis, and intracellular PRRs (",
"    <a class=\"graphic graphic_table graphicRef66228 \" href=\"UTD.htm?38/50/39724\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9421044\">",
"    <span class=\"h2\">",
"     Toll-like receptors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Toll-like receptors are transmembrane PRRs that are found on and within cells of the innate immune system (particularly monocytes, macrophages, epithelial cells, and neutrophils), as well as dendritic cells and many other cell types [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/3-8\">",
"     3-8",
"    </a>",
"    ]. TLRs recognize a variety of PAMPS, including microbial cell wall components, proteins, and nucleic acids (",
"    <a class=\"graphic graphic_table graphicRef55974 \" href=\"UTD.htm?13/25/13724\">",
"     table 3",
"    </a>",
"    ). TLR signaling results in changes in the transcription factors that regulate a multitude of genes, including those encoding important proinflammatory cytokines. Drosophila Toll signals dorsoventral patterning and resistance to fungi in fruit flies and has a cytoplasmic signaling domain homologous with that of mammalian TLRs [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/42\">",
"     42",
"    </a>",
"    ]. The sea urchin has 222 TLRs, illustrating the importance of these receptors to host defense throughout phylogeny [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/43\">",
"     43",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/54/23401?source=see_link\">",
"     \"Toll-like receptors: Roles in disease and therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Ten human TLRs have been identified to date (",
"    <a class=\"graphic graphic_table graphicRef55974 \" href=\"UTD.htm?13/25/13724\">",
"     table 3",
"    </a>",
"    ). The first human TLR identified was TLR4, which is constitutively expressed on many human cell types. TLR4 is specific for and exquisitely sensitive to the presence of bacterial endotoxin. Picogram amounts of endotoxin (estimated to equal ~10 LPS molecules per cell) are sufficient to stimulate immune cells through TLR4 [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/44\">",
"     44",
"    </a>",
"    ]. TLRs are homologous with the mammalian IL-1 receptor [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/45\">",
"     45",
"    </a>",
"    ]. TLRs and the mammalian IL-1 receptor share a MyD88-dependent signaling pathway that induces the transcription factors nuclear factor for the kappa light chain enhancer in B cells (NF-kappa B) and activating protein-1 (AP-1). These factors transcribe the secretion of potent proinflammatory cytokines, including tumor necrosis factor (TNF), interleukin (IL)-6, and proIL-1&beta;.",
"   </p>",
"   <p>",
"    The central role of TLRs in host defense is demonstrated by experiments of nature in which genetic polymorphisms or mutations are associated with disease. Predisposition to serious viral infections illustrates this point. Five of the 10 TLRs (TLRs 3, 4, 7, 8, and 9) can trigger production of type-1 interferons (IFNs) (IFN-&alpha;, IFN-&beta;, and IFN-&lambda;), which are essential for antiviral immunity. Patients with deficiency of TLR3 [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/46\">",
"     46",
"    </a>",
"    ]; the TLR 3,7,8,9 signaling molecule UNC-93B [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/47\">",
"     47",
"    </a>",
"    ]; or the signal transducer and activator of transcription (STAT)-1 signaling molecule [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/48\">",
"     48",
"    </a>",
"    ] have suffered severe viral infections, particularly herpes simplex virus-1 encephalitis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/49\">",
"     49",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/54/23401?source=see_link&amp;anchor=H5549596#H5549596\">",
"     \"Toll-like receptors: Roles in disease and therapy\", section on 'UNC93B deficiency and TLR3 mutations'",
"    </a>",
"    .) Polymorphisms in TLRs have been associated with impaired resistance to respiratory syncytial virus [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/50\">",
"     50",
"    </a>",
"    ] and increased risk of invasive fungal infections [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/51\">",
"     51",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/54/23401?source=see_link\">",
"     \"Toll-like receptors: Roles in disease and therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9421051\">",
"    <span class=\"h2\">",
"     PRRs linked to phagocytosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Phagocytes express membrane-bound PRRs on their cell surface, which often function in concert with the secreted PRRs. When these cell surface PRRs bind PAMPs, they initiate phagocytosis, release of toxic oxidants, and delivery of pathogens to lysosomes filled with microbicidal products. In macrophages, pathogen-derived proteins are also processed into peptides and presented by major-histocompatibility-complex (MHC) molecules on the cell surface to engage and instruct antigen-specific T lymphocytes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/53/25432?source=see_link\">",
"     \"Antigen presenting cells\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The best-studied PRRs found on macrophages include the following (",
"    <a class=\"graphic graphic_table graphicRef66228 \" href=\"UTD.htm?38/50/39724\">",
"     table 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The macrophage mannose receptor recognizes carbohydrates with terminal mannan that are characteristic of a variety of microbes, especially fungi [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/32,52\">",
"       32,52",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Certain members of the macrophage scavenger-receptor family can bind to bacterial cell walls and trigger phagocytic clearance of bacteria [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/53-55\">",
"       53-55",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Dectin 1 is a transmembrane C-type lectin receptor expressed on human macrophages, monocytes, neutrophils, eosinophils, dendritic cells, and lymphocytes [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/56-58\">",
"       56-58",
"      </a>",
"      ]. It has binding specificity for &beta;-1,3-glucans, an important component of fungal cell walls. Mutations leading to deficient expression of dectin-1 have been reported in women with recurrent mucocutaneous fungal infections, particularly vulvovaginal candidiasis and onychomycosis [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/59\">",
"       59",
"      </a>",
"      ]. Phagocytosis and killing of fungi by leukocytes from these individuals was normal, emphasizing the special role of dectin-1 in defense of skin and mucosa. An autosomal recessive mutation in caspase recruitment-containing domain 9 (CARD9), which is involved in signaling from dectin-1, has been associated with chronic mucocutaneous candidiasis [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/60\">",
"       60",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Another example of a membrane-bound PRR that promotes phagocytosis is the N-formylmethionine receptor, which is expressed on neutrophils, monocytes, macrophages, and dendritic cells. The amino acid sequence N-formylmethionine initiates all bacterial proteins, but only mitochondrial proteins in mammalian cells [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/61\">",
"     61",
"    </a>",
"    ]. Engagement of these bacterial structures by the N-formylmethionine receptor on host cells that express this receptor chemoattracts these cells and activates them for phagocytosis and killing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9421058\">",
"    <span class=\"h2\">",
"     Intracellular PRRs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intracellular PRRs include some of the TLRs, the NOD-like receptors, and the RIG-I like receptor family (",
"    <a class=\"graphic graphic_table graphicRef66228 \" href=\"UTD.htm?38/50/39724\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      TLRs 3, 7, 8, 9, and 10 reside inside the cell in endolysosomes, membrane-bound compartments that contain bacterial breakdown products or viruses and digestive enzymes from fused lysosomes. Here they recognize nucleic acids derived from viruses and bacteria and stimulate the production of",
"      <span class=\"nowrap\">",
"       IFNs-&alpha;/&beta;/&lambda;",
"      </span>",
"      and proinflammatory cytokines. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/54/23401?source=see_link\">",
"       \"Toll-like receptors: Roles in disease and therapy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The NOD-like receptors, NOD1 and NOD2, are PRRs that reside in the cytoplasm and recognize different structural core motifs of bacterial peptidoglycans [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/3,4,7,8,62\">",
"       3,4,7,8,62",
"      </a>",
"      ]. NOD1 recognizes peptidoglycan of all Gram-negative bacteria and certain Gram-positive bacteria. NOD2 recognizes muramyl dipeptide, a peptidoglycan motif present in all Gram-positive and -negative bacteria [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/3,7,62-64\">",
"       3,7,62-64",
"      </a>",
"      ]. NOD2 expression is restricted to monocytes, macrophages, dendritic cells, epithelial and endothelial cells, and intestinal Paneth cells. TNF-&alpha; and IFN-&gamma; can upregulate the NOD2 gene in intestinal epithelial cells [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/65\">",
"       65",
"      </a>",
"      ]. Engagement of either NOD1 or NOD2 activates NF-&kappa;B, which results in upregulated transcription and production of proinflammatory mediators. NOD2 has been of particular interest in Crohn's disease because three polymorphisms in the NOD2 gene are associated with a 2- to 4-fold risk of this disorder in heterozygotes and an 11- to 27-fold risk in homozygotes [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/66,67\">",
"       66,67",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27401?source=see_link&amp;anchor=H4#H4\">",
"       \"Immune and microbial mechanisms in the pathogenesis of inflammatory bowel disease\", section on 'Immune dysregulation and IBD'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The RIG-I-like receptor family is a second family of cytoplasmic PRRs. It consists of retinoic acid-inducible gene I (RIG-I), melanoma differentiation-associated gene 5 (MDA5), and laboratory of genetics and physiology 2 (LPG2). These PRRs recognize the RNA of viruses and mediate production of type-1 IFNs and antiviral immune responses [",
"      <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/3,4,8,68\">",
"       3,4,8,68",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9421065\">",
"    <span class=\"h1\">",
"     CELLS OF THE INNATE IMMUNE SYSTEM",
"    </span>",
"    &nbsp;&mdash;&nbsp;The &ldquo;professional&rdquo; phagocytes: neutrophils, monocytes, and macrophages, represent the critical effector component of the innate immune system [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/69-71\">",
"     69-71",
"    </a>",
"    ]. Other cell types express PRRs, including TLRs, and play an important contributory role in innate host defense, including epithelial cells, mast cells, and platelets. Dendritic cells express PRRs and, as principal antigen presenting cells, serve to link innate and adaptive immunity [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/72,73\">",
"     72,73",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/22/44393?source=see_link&amp;anchor=H14#H14\">",
"     \"Mast cells: Development, identification, and physiologic roles\", section on 'Innate immunity'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9421072\">",
"    <span class=\"h2\">",
"     Neutrophils",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neutrophils, the most abundant circulating phagocytes in humans, are the first cells recruited into sites of infection and inflammation, attracted by a variety of chemotactic signals generated at these sites. These signals are recognized by PRRs for N-formyl bacterial oligopeptide and by receptors for complement-derived C5a, leukotriene B4 (secreted by numerous immune cells upon activation), and the neutrophil chemokine IL-8, which is secreted by activated innate immune cells and epithelial cells. Certain antimicrobial peptides are also chemotactic for neutrophils [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/74\">",
"     74",
"    </a>",
"    ]. All of these neutrophil chemoattractants diffuse from the site of infection and injury to provide a chemotactic gradient for neutrophil migration and to further activate neutrophils as they transmigrate. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/54/36711?source=see_link\">",
"     \"Leukocyte-endothelial adhesion in the pathogenesis of inflammation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Upon reaching the infected site, neutrophils phagocytose invading microorganisms that are opsonized by innate and acquired immune processes, such as fixation of complement C3 fragments and IgG. Complement receptor 1 (CR1) and CR3 are the main phagocytic receptors for opsonic C3b and iC3b, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/33\">",
"     33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/59/11190?source=see_link\">",
"     \"Complement pathways\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Following phagocytosis, microbicidal mechanisms kill the ingested microbes almost immediately by merging the microbe-containing phagosome with intracellular granules containing microbicidal products such as alpha-defensins (human neutrophil peptides 1 through 4) and highly reactive oxidizing agents generated by the phagocyte NADPH oxidase (O2-, H2O2, hypochlorous acid, hydroxyl radical) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/69,74,75\">",
"     69,74,75",
"    </a>",
"    ]. The phagocyte NADPH oxidase has an essential role in killing and preventing infection with certain common organisms (eg, staphylococci, enteric bacteria, and Aspergillus), as evidenced by chronic granulomatous disease, in which the phagocyte oxidase is deficient [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/76\">",
"     76",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/38/43620?source=see_link\">",
"     \"Primary disorders of phagocytic function: An overview\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/36/10826?source=see_link\">",
"     \"Chronic granulomatous disease: Pathogenesis, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Neutrophil cytoplasmic granule proteases (neutrophil elastase and cathepsin G) are also important to neutrophil microbicidal function. These cationic proteases, usually bound and rendered inactive by proteoglycans, are released with K+ ion fluxes into alkalinized phagocytic vacuoles, thereby activating the proteases [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/77\">",
"     77",
"    </a>",
"    ]. These pH and potassium requirements for protease solubilization and activity restrict their maximal toxicity to phagocytic vacuoles and limit damage to host tissues.",
"   </p>",
"   <p>",
"    In a normal adult, about 100 billion neutrophils leave the marrow, circulate, enter tissues, and die each day, even in the absence of acute infection [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/78\">",
"     78",
"    </a>",
"    ]. Considered together, these cells travel a distance equivalent to &gt;twice around the earth [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/79\">",
"     79",
"    </a>",
"    ]. Such a constant stream of dying neutrophils would be potently inflammatory without the process of efferocytosis (from the Latin &ldquo;to take to the grave&rdquo; or &ldquo;to bury&rdquo;). Efferocytosis refers to the uptake and processing of apoptotic cells by macrophages and dendritic cells [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/80\">",
"     80",
"    </a>",
"    ]. Phagocytic removal of apoptotic neutrophils prevents the release of their toxic constituents by necrosis. Moreover, this process shifts macrophage cytokine release from proinflammatory to antiinflammatory, further moving the process towards resolution [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/81\">",
"     81",
"    </a>",
"    ]. Thus, efferocytosis is central to the successful resolution of inflammation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9421079\">",
"    <span class=\"h2\">",
"     Monocytes and macrophages",
"    </span>",
"    &nbsp;&mdash;&nbsp;Monocytes, the circulating precursors of macrophages, develop in the bone marrow and remain longer in the circulation than do neutrophils. They enter tissues where they undergo considerable differentiation into macrophages that are characteristic for the tissue in which they reside, eg, interstitial and alveolar macrophages in the lung, Kupffer cells in the liver, osteoclasts in bone, and microglial cells in the brain and retina. Macrophages express a high density of surface PRRs and, like neutrophils, respond rapidly to the presence of microbes. These two cell types complement and cooperate in effecting innate immunity [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/70\">",
"     70",
"    </a>",
"    ], but they differ in several important ways. Among these, macrophages have an important role in digesting microbes and presenting microbial antigens to lymphocytes to initiate an adaptive immune response to the microbe. In addition, macrophages secrete over 100 proteins that mediate host defense and inflammation, including potent cytokines. However, inflammation is the classic &ldquo;double-edged sword,&rdquo; and macrophages cut both ways. Central nervous system microglia illustrates this point. These cells presumably evolved to protect the brain from microbial assault, but a common feature of neurodegenerative diseases, including Alzheimer&rsquo;s and Parkinson&rsquo;s diseases, viral encephalopathy, stroke, traumatic brain injury, and multiple sclerosis, is immune activation in which microglia are key perpetrators [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/82,83\">",
"     82,83",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9421086\">",
"    <span class=\"h2\">",
"     Natural killer cells",
"    </span>",
"    &nbsp;&mdash;&nbsp;Natural killer (NK) cells are an innate immune cell type with unique features. They are lymphoid cells that do not express antigen-specific receptors derived from recombination and clonal selection, such as T-cell receptors or surface immunoglobulin. However, studies in mice have suggested that NK cells can alter their behavior based on prior exposure to particular antigens, including after viral infection, by a mechanism that is different from that of T and B cells [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/84,85\">",
"     84,85",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    NK cells express PRRs, including TLRs 2, 3, 4, 5, 7, and 8, and recognize and respond to the respective TLR ligands directly [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/86,87\">",
"     86,87",
"    </a>",
"    ]. They are best known for responding to viral infections (especially herpes simplex infections) and malignant tumors by recognizing damaged or stressed host cells for elimination. NK cells distinguish healthy host cells through inhibitory receptors such as the \"killer cell immunoglobulin-like receptor\" (KIR) and CD94-NKG2A receptors, which recognize MHC class I molecules expressed on healthy cells [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/88,89\">",
"     88,89",
"    </a>",
"    ]. Binding of these receptors inhibits NK cell-mediated lysis and cytokine secretion, whereas deficiency or absence of surface MHC I will target that cell for attack. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/10/30889?source=see_link&amp;anchor=H2#H2\">",
"     \"NK cell deficiency syndromes: Clinical manifestations and diagnosis\", section on 'Biology of NK cells'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Virus-infected and malignant cells often downregulate MHC class I molecules, rendering them susceptible to attack by NK cells [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/90\">",
"     90",
"    </a>",
"    ]. The inhibitory receptors on NK cells are counterbalanced by activating receptors, such as the NKG2D receptor that recognizes \"stress\" ligands expressed on cell surfaces in response to intracellular DNA damage [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/91\">",
"     91",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Recruited and activated NK cells mediate antimicrobial activities through the induction of apoptosis of cell targets, and more broadly, through cytokine secretion that promotes innate immune functions and contributes to the adaptive immune response. NK cells have granules with perforins and granzymes that, upon activation, are released into the synapse between target and effector cell, disrupting target cell membranes and inducing apoptosis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/92\">",
"     92",
"    </a>",
"    ]. Activated NK cells are known particularly for their secretion of IFN-&gamma;, but they also secrete TNF-&alpha;, growth factors, IL-5, IL-10, IL-13, and chemokines [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/93\">",
"     93",
"    </a>",
"    ]. Dendritic cells recruit, interact with, and activate NK cells through cytokines (eg, type I IFNs, IL-12, IL-18) and cell-to-cell surface interactions [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/93,94\">",
"     93,94",
"    </a>",
"    ]. In the give and take between the host and an infecting virus [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/95\">",
"     95",
"    </a>",
"    ], NK cells play a central role, as confirmed by the serious herpesvirus infections sustained by a boy lacking NK cells [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/96\">",
"     96",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9421093\">",
"    <span class=\"h2\">",
"     Other cell types",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epithelial cells and mast cells function as additional tissue-based sentinels. Like macrophages, these cells reside in tissue areas of high antigenic exposure and express PRRs that allow them to recognize PAMPs and respond quickly. Epithelial cells provide a continuous physical barrier, as well as clearance mechanisms (eg, mucociliary system and surface coating with antimicrobial peptides) to protect the host from the external environment. Human airway epithelial cells express multiple TLRs and when PAMP-stimulated, produce proinflammatory cytokines, including IL-8 [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/97\">",
"     97",
"    </a>",
"    ]. Human keratinocytes express a mannose-binding receptor that mediates killing of candida [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/98\">",
"     98",
"    </a>",
"    ]. In the GI tract, TLR-mediated epithelial responses to commensal bacterial PAMPs (ie, TLR4 and TLR2 ligands) promote epithelial integrity and resilience to injury [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/99\">",
"     99",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mast cells reside in large numbers in the interstitium of peripheral tissues. They express TLRs 1, 2, 4, and 6 [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/100,101\">",
"     100,101",
"    </a>",
"    ], complement receptors for C5a [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/102\">",
"     102",
"    </a>",
"    ], and receptors for mannose-binding lectin. Upon PRR activation, mast cells release TNF-&alpha; and IL-8, which are uniquely preformed in mast cells. The immediate release of TNF-&alpha; may have a central role in effective antimicrobial responses to infections [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/103\">",
"     103",
"    </a>",
"    ]. Mast cells also make classic inflammatory mediators (histamine,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    , leukotrienes, platelet-activating factor), proteases (eg, tryptase, chymase), and antimicrobial peptides (cathelicidin LL-37 and defensins) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/104\">",
"     104",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/22/44393?source=see_link\">",
"     \"Mast cells: Development, identification, and physiologic roles\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/28/20936?source=see_link\">",
"     \"Mast cells: Surface receptors and signal transduction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/6/34921?source=see_link\">",
"     \"Mast cell derived mediators\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Platelets are long known to protect us against bleeding to death, but they are a relatively new entry to the pantheon of defenders of the host against infection [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/105,106\">",
"     105,106",
"    </a>",
"    ]. They express PRRs, produce cytokines, recruit leukocytes to sites of tissue damage, and interact with leukocytes and endothelial cells through P-selectin to mediate proinflammatory events [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/105\">",
"     105",
"    </a>",
"    ]. Like other components of the inflammatory process, however, their roles in mediating inflammation involve them in pathological conditions, such as atherosclerosis and sepsis syndrome.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5719882\">",
"    <span class=\"h1\">",
"     HOMEOSTASIS IN THE INNATE IMMUNE SYSTEM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although humans exist day-to-day in a hostile microbe-laden environment, we are normally unaware of the constant battles waged to prevent our becoming infected. For those with a normal immune system, infection-induced inflammation is relatively uncommon; and when it occurs, it disappears as soon as the battle is over. This potent but unapparent immune protection of the well-defended host is a reflection of the quiet efficiency of front-line defenses (eg, antimicrobial peptides, complement, and phagocytes) combined with active homeostatic processes within the innate immune system that regulate the inflammatory response. A few examples illustrate this point:",
"   </p>",
"   <p>",
"    Macrophages are essential for host defense, but they also play a central role in maintaining immune homeostasis. Pulmonary alveolar macrophages can actively suppress dendritic cell maturation, antigen presentation, and function in mouse airways [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/107\">",
"     107",
"    </a>",
"    ].",
"    <span class=\"nowrap\">",
"     PAMP/PRR",
"    </span>",
"    activation temporarily diverts alveolar macrophages from their antiinflammatory mode and primes them for antimicrobial functions [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/108,109\">",
"     108,109",
"    </a>",
"    ]. Classical activation of macrophages induces not only proinflammatory responses, but also the antiinflammatory mediators IL-10, TGF-&beta;, and PGE2, that downregulate macrophage and dendritic cell functions. Thus, microbe-induced activation of the innate immune system is tightly linked to the concurrent induction of down-regulatory mechanisms to regain immune homeostasis.",
"   </p>",
"   <p>",
"    Macrophages also control inflammation through their ability to rapidly ingest and clear apoptotic cells, the process of efferocytosis by which more than 10",
"    <sup>",
"     11",
"    </sup>",
"    circulating neutrophils are eliminated each day without detectable inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/80\">",
"     80",
"    </a>",
"    ]. Apoptotic cells and autolyzed, necrotic neutrophils release cytotoxic, proinflammatory constituents into their environment unless countered by this constitutive antiinflammatory process of apoptotic cell recognition and ingestion. The pathogenicity of some bacteria depends on their release of cytotoxins that induce phagocyte necrosis and temporarily overwhelm efferocytosis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/110\">",
"     110",
"    </a>",
"    ]. High mobility group box 1 (HMGB1), a DNA-binding nuclear protein released from disrupted cells, is a potent mediator of inflammation through its capacity to diminish phagocytic uptake of apoptotic cells [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/111\">",
"     111",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Macrophages recognize apoptotic cells through recognition of molecular patterns, reminiscent of microbial recognition by innate immune cells. The plasma membrane of viable cells actively maintains an asymmetric phospholipid distribution such that phosphatidylserine is kept on the inner side of the membrane bilayer. Apoptosis perturbs this asymmetry and exposes phosphatidylserine on the cell&rsquo;s outer surface, leading to their recognition by macrophages bearing phosphatidylserine receptors [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/112-114\">",
"     112-114",
"    </a>",
"    ]. Upon recognition of apoptotic cells, macrophages release antiinflammatory IL-10, PGE2, and TGF-&beta; to complete the task of maintaining immune homeostasis. In turn, the apoptotic pathway in monocytes and macrophages themselves is regulated by a complex network of differentiation factors and inflammatory stimuli that determine lifespan [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/115\">",
"     115",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Individuals with chronic granulomatous disease (CGD) suffer severe bacterial and fungal infections on one hand, and on the other, various inflammatory disorders, such as sterile inflammation and inflammatory bowel disease [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/116\">",
"     116",
"    </a>",
"    ]. This apparently contradictory combination of problems has been attributed to the dual functions of NADPH oxidase, which is defective in the neutrophils and macrophages of patients with this disease. Infections result from defective generation of microbicidal oxygen metabolites, such as",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/41/41617?source=see_link\">",
"     hydrogen peroxide",
"    </a>",
"    , by NADPH oxidase in neutrophils and macrophages during phagocytosis. Excessive inflammation is attributed to a defect in the regulation of inflammation by NADPH oxidase, and studies with murine and human CGD show failure during phagocytosis to activate Nrf2, a key redox-sensitive antiinflammatory regulator [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/117\">",
"     117",
"    </a>",
"    ]. In addition, CGD macrophages do not ingest apoptotic neutrophils normally [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/118\">",
"     118",
"    </a>",
"    ]; this can be reversed by exposure of the macrophages to the key macrophage activator IFN-&gamma; [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/119\">",
"     119",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The complement component C1q and the collectins, mannose-binding lectin and surfactant proteins A and D, can bind to apoptotic cells and mediate their clearance [",
"    <a class=\"abstract\" href=\"UTD.htm?16/37/16986/abstract/120\">",
"     120",
"    </a>",
"    ]. Although macrophages have received most of the attention in mediating efferocytosis, other cell types can perform the same functions, including epithelial and endothelial cells, fibroblasts, and stromal cells. The relative extent to which each cell type contributes is not well-defined.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9421100\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The innate immune system refers to germline defense mechanisms that are directed against molecular components found only in microorganisms. These mechanisms are not learned, adapted, or permanently heightened as a result of exposure to microorganisms, although they are refined by evolution over generations. (See",
"      <a class=\"local\" href=\"#H9420979\">",
"       'Innate versus adaptive immunity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In addition to providing a first line of defense against microbes, the innate immune system activates and instructs adaptive immune responses, regulates inflammation, and mediates immune homeostasis (the balance between opposing proinflammatory and antiinflammatory processes). (See",
"      <a class=\"local\" href=\"#H23899400\">",
"       'Components and functions of the innate immune system'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The cells of the innate immune system use pattern recognition receptors (PRRs), which recognize pathogen-associated molecular patterns (PAMPs) on microorganisms, and communicate through cytokines (",
"      <a class=\"graphic graphic_table graphicRef53389 \" href=\"UTD.htm?23/35/24124\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef66228 \" href=\"UTD.htm?38/50/39724\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H9420986\">",
"       'Microbial detection through pattern recognition'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9421008\">",
"       'Prototypic PRRs: Secreted and circulating'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9421192\">",
"       'Prototypic PRRs: Cell-associated'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Activation of the innate immune system begins with resident cells in the tissues at the site of the insult (macrophages, epithelial cells, mast cells). If the threat of infection accelerates, these cells recruit other cells (neutrophils, NK cells, dendritic cells, monocytes, platelets) from the circulation into the inflamed tissues. (See",
"      <a class=\"local\" href=\"#H9421065\">",
"       'Cells of the innate immune system'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Many of the same cells and mechanisms used to recognize and attack microbes and initiate inflammatory reactions are also used to clear away damaged and dying cells and downregulate inflammation to maintain homeostasis within the host.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/1\">",
"      Travis J. Origins. On the origin of the immune system. Science 2009; 324:580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/2\">",
"      Boller T, He SY. Innate immunity in plants: an arms race between pattern recognition receptors in plants and effectors in microbial pathogens. Science 2009; 324:742.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/3\">",
"      Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010; 140:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/4\">",
"      Kumagai Y, Akira S. Identification and functions of pattern-recognition receptors. J Allergy Clin Immunol 2010; 125:985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/5\">",
"      Beutler BA. TLRs and innate immunity. Blood 2009; 113:1399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/6\">",
"      Blasius AL, Beutler B. Intracellular toll-like receptors. Immunity 2010; 32:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/7\">",
"      Shaw MH, Reimer T, Kim YG, Nu&ntilde;ez G. NOD-like receptors (NLRs): bona fide intracellular microbial sensors. Curr Opin Immunol 2008; 20:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/8\">",
"      Wilkins C, Gale M Jr. Recognition of viruses by cytoplasmic sensors. Curr Opin Immunol 2010; 22:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/9\">",
"      Rietschel ET, Kirikae T, Schade FU, et al. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 1994; 8:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/10\">",
"      Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002; 415:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/11\">",
"      Doss M, White MR, Tecle T, Hartshorn KL. Human defensins and LL-37 in mucosal immunity. J Leukoc Biol 2010; 87:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/12\">",
"      Underwood MA, Bevins CL. Defensin-barbed innate immunity: clinical associations in the pediatric population. Pediatrics 2010; 125:1237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/13\">",
"      Steinstraesser L, Kraneburg U, Jacobsen F, Al-Benna S. Host defense peptides and their antimicrobial-immunomodulatory duality. Immunobiology 2011; 216:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/14\">",
"      Ouellette AJ. Paneth cells and innate mucosal immunity. Curr Opin Gastroenterol 2010; 26:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/15\">",
"      Tecle T, Tripathi S, Hartshorn KL. Review: Defensins and cathelicidins in lung immunity. Innate Immun 2010; 16:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/16\">",
"      Lee DJ, Modlin RL. DNA transportation authority. Nat Med 2008; 14:1319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/17\">",
"      Vora P, Youdim A, Thomas LS, et al. Beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells. J Immunol 2004; 173:5398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/18\">",
"      Birchler T, Seibl R, B&uuml;chner K, et al. Human Toll-like receptor 2 mediates induction of the antimicrobial peptide human beta-defensin 2 in response to bacterial lipoprotein. Eur J Immunol 2001; 31:3131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/19\">",
"      Wang TT, Nestel FP, Bourdeau V, et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 2004; 173:2909.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/20\">",
"      Schauber J, Dorschner RA, Coda AB, et al. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest 2007; 117:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/21\">",
"      Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311:1770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/22\">",
"      Zasloff M. Fighting infections with vitamin D. Nat Med 2006; 12:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/23\">",
"      Chertov O, Yang D, Howard OM, Oppenheim JJ. Leukocyte granule proteins mobilize innate host defenses and adaptive immune responses. Immunol Rev 2000; 177:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/24\">",
"      Niyonsaba F, Iwabuchi K, Matsuda H, et al. Epithelial cell-derived human beta-defensin-2 acts as a chemotaxin for mast cells through a pertussis toxin-sensitive and phospholipase C-dependent pathway. Int Immunol 2002; 14:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/25\">",
"      Niyonsaba F, Iwabuchi K, Someya A, et al. A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology 2002; 106:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/26\">",
"      Salzman NH, Hung K, Haribhai D, et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 2010; 11:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/27\">",
"      Epstein J, Eichbaum Q, Sheriff S, Ezekowitz RA. The collectins in innate immunity. Curr Opin Immunol 1996; 8:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/28\">",
"      Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 2005; 5:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/29\">",
"      Wu H, Kuzmenko A, Wan S, et al. Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J Clin Invest 2003; 111:1589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/30\">",
"      McCormack FX, Gibbons R, Ward SR, et al. Macrophage-independent fungicidal action of the pulmonary collectins. J Biol Chem 2003; 278:36250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/31\">",
"      Lee DC, Romero R, Kim CJ, et al. Surfactant protein-A as an anti-inflammatory component in the amnion: implications for human pregnancy. J Immunol 2010; 184:6479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/32\">",
"      Fraser IP, Koziel H, Ezekowitz RA. The serum mannose-binding protein and the macrophage mannose receptor are pattern recognition molecules that link innate and adaptive immunity. Semin Immunol 1998; 10:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/33\">",
"      Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol 2010; 11:785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/34\">",
"      Stowell SR, Arthur CM, Dias-Baruffi M, et al. Innate immune lectins kill bacteria expressing blood group antigen. Nat Med 2010; 16:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/35\">",
"      Jack DL, Klein NJ, Turner MW. Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis. Immunol Rev 2001; 180:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/36\">",
"      Botto M, Kirschfink M, Macor P, et al. Complement in human diseases: Lessons from complement deficiencies. Mol Immunol 2009; 46:2774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/37\">",
"      Liu FT, Bevins CL. A sweet target for innate immunity. Nat Med 2010; 16:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/38\">",
"      Garlanda C, Bottazzi B, Bastone A, Mantovani A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol 2005; 23:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/39\">",
"      Mantovani A, Garlanda C, Doni A, Bottazzi B. Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3. J Clin Immunol 2008; 28:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/40\">",
"      Bottazzi B, Doni A, Garlanda C, Mantovani A. An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu Rev Immunol 2010; 28:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/41\">",
"      Deban L, Russo RC, Sironi M, et al. Regulation of leukocyte recruitment by the long pentraxin PTX3. Nat Immunol 2010; 11:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/42\">",
"      Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 2007; 449:819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/43\">",
"      Rast JP, Smith LC, Loza-Coll M, et al. Genomic insights into the immune system of the sea urchin. Science 2006; 314:952.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/44\">",
"      Pabst MJ, Hedegaard HB, Johnston RB Jr. Cultured human monocytes require exposure to bacterial products to maintain an optimal oxygen radical response. J Immunol 1982; 128:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/45\">",
"      Gay NJ, Keith FJ. Drosophila Toll and IL-1 receptor. Nature 1991; 351:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/46\">",
"      Zhang SY, Jouanguy E, Ugolini S, et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 2007; 317:1522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/47\">",
"      Casrouge A, Zhang SY, Eidenschenk C, et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 2006; 314:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/48\">",
"      Dupuis S, Jouanguy E, Al-Hajjar S, et al. Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nat Genet 2003; 33:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/49\">",
"      Zhang SY, Jouanguy E, Sancho-Shimizu V, et al. Human Toll-like receptor-dependent induction of interferons in protective immunity to viruses. Immunol Rev 2007; 220:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/50\">",
"      Tulic MK, Hurrelbrink RJ, Pr&ecirc;le CM, et al. TLR4 polymorphisms mediate impaired responses to respiratory syncytial virus and lipopolysaccharide. J Immunol 2007; 179:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/51\">",
"      Pamer EG. TLR polymorphisms and the risk of invasive fungal infections. N Engl J Med 2008; 359:1836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/52\">",
"      Netea MG, Gow NA, Munro CA, et al. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J Clin Invest 2006; 116:1642.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/53\">",
"      Thomas CA, Li Y, Kodama T, et al. Protection from lethal gram-positive infection by macrophage scavenger receptor-dependent phagocytosis. J Exp Med 2000; 191:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/54\">",
"      Fabriek BO, van Bruggen R, Deng DM, et al. The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria. Blood 2009; 113:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/55\">",
"      Thelen T, Hao Y, Medeiros AI, et al. The class A scavenger receptor, macrophage receptor with collagenous structure, is the major phagocytic receptor for Clostridium sordellii expressed by human decidual macrophages. J Immunol 2010; 185:4328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/56\">",
"      Willment JA, Marshall AS, Reid DM, et al. The human beta-glucan receptor is widely expressed and functionally equivalent to murine Dectin-1 on primary cells. Eur J Immunol 2005; 35:1539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/57\">",
"      Levitz SM. Innate recognition of fungal cell walls. PLoS Pathog 2010; 6:e1000758.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/58\">",
"      Marakalala MJ, Kerrigan AM, Brown GD. Dectin-1: a role in antifungal defense and consequences of genetic polymorphisms in humans. Mamm Genome 2011; 22:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/59\">",
"      Ferwerda B, Ferwerda G, Plantinga TS, et al. Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med 2009; 361:1760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/60\">",
"      Glocker EO, Hennigs A, Nabavi M, et al. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med 2009; 361:1727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/61\">",
"      Le Y, Yang Y, Cui Y, et al. Receptors for chemotactic formyl peptides as pharmacological targets. Int Immunopharmacol 2002; 2:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/62\">",
"      Inohara N, Nu&ntilde;ez G. NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol 2003; 3:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/63\">",
"      Inohara N, Ogura Y, Fontalba A, et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem 2003; 278:5509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/64\">",
"      Girardin SE, Boneca IG, Viala J, et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003; 278:8869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/65\">",
"      Rosenstiel P, Fantini M, Br&auml;utigam K, et al. TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 2003; 124:1001.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/66\">",
"      Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med 2009; 361:2066.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/67\">",
"      Economou M, Trikalinos TA, Loizou KT, et al. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol 2004; 99:2393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/68\">",
"      Kato H, Takeuchi O, Sato S, et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006; 441:101.",
"     </a>",
"    </li>",
"    <li>",
"     Johnston RB Jr, Babior BM. The polymorphonuclear leukocyte system. In: Immunologic disorders in infants and children, 5th ed, Stiehm ER, Ochs HD, Winkelstein JA (Eds), Saunders/Elsevier, Philadelphia 2004. p.109.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/70\">",
"      Silva MT. When two is better than one: macrophages and neutrophils work in concert in innate immunity as complementary and cooperative partners of a myeloid phagocyte system. J Leukoc Biol 2010; 87:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/71\">",
"      Serbina NV, Jia T, Hohl TM, Pamer EG. Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol 2008; 26:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/72\">",
"      Rossi M, Young JW. Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity. J Immunol 2005; 175:1373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/73\">",
"      Liu K, Nussenzweig MC. Origin and development of dendritic cells. Immunol Rev 2010; 234:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/74\">",
"      Rehaume LM, Hancock RE. Neutrophil-derived defensins as modulators of innate immune function. Crit Rev Immunol 2008; 28:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/75\">",
"      Nauseef WM. How human neutrophils kill and degrade microbes: an integrated view. Immunol Rev 2007; 219:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/76\">",
"      Winkelstein JA, Marino MC, Johnston RB Jr, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 2000; 79:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/77\">",
"      Reeves EP, Lu H, Jacobs HL, et al. Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature 2002; 416:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/78\">",
"      Walker RI, Willemze R. Neutrophil kinetics and the regulation of granulopoiesis. Rev Infect Dis 1980; 2:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/79\">",
"      Stossel TP. The E. Donnall Thomas Lecture, 1993. The machinery of blood cell movements. Blood 1994; 84:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/80\">",
"      Vandivier RW, Henson PM, Douglas IS. Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. Chest 2006; 129:1673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/81\">",
"      Fox S, Leitch AE, Duffin R, et al. Neutrophil apoptosis: relevance to the innate immune response and inflammatory disease. J Innate Immun 2010; 2:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/82\">",
"      Tambuyzer BR, Ponsaerts P, Nouwen EJ. Microglia: gatekeepers of central nervous system immunology. J Leukoc Biol 2009; 85:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/83\">",
"      Amor S, Puentes F, Baker D, van der Valk P. Inflammation in neurodegenerative diseases. Immunology 2010; 129:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/84\">",
"      Paust S, Senman B, von Andrian UH. Adaptive immune responses mediated by natural killer cells. Immunol Rev 2010; 235:286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/85\">",
"      Cooper MA, Yokoyama WM. Memory-like responses of natural killer cells. Immunol Rev 2010; 235:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/86\">",
"      Lauzon NM, Mian F, MacKenzie R, Ashkar AA. The direct effects of Toll-like receptor ligands on human NK cell cytokine production and cytotoxicity. Cell Immunol 2006; 241:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/87\">",
"      Hart OM, Athie-Morales V, O'Connor GM, Gardiner CM. TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production. J Immunol 2005; 175:1636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/88\">",
"      Wagtmann N, Rajagopalan S, Winter CC, et al. Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity 1995; 3:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/89\">",
"      Lazetic S, Chang C, Houchins JP, et al. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol 1996; 157:4741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/90\">",
"      Cerwenka A, Lanier LL. Natural killer cells, viruses and cancer. Nat Rev Immunol 2001; 1:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/91\">",
"      Gasser S, Raulet DH. Activation and self-tolerance of natural killer cells. Immunol Rev 2006; 214:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/92\">",
"      Trapani JA, Smyth MJ. Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2002; 2:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/93\">",
"      Andoniou CE, Andrews DM, Degli-Esposti MA. Natural killer cells in viral infection: more than just killers. Immunol Rev 2006; 214:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/94\">",
"      Moretta L, Ferlazzo G, Bottino C, et al. Effector and regulatory events during natural killer-dendritic cell interactions. Immunol Rev 2006; 214:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/95\">",
"      Rouse BT, Sehrawat S. Immunity and immunopathology to viruses: what decides the outcome? Nat Rev Immunol 2010; 10:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/96\">",
"      Biron CA, Byron KS, Sullivan JL. Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 1989; 320:1731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/97\">",
"      Nakanaga T, Nadel JA, Ueki IF, et al. Regulation of interleukin-8 via an airway epithelial signaling cascade. Am J Physiol Lung Cell Mol Physiol 2007; 292:L1289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/98\">",
"      Szolnoky G, Bata-Cs&ouml;rg&ouml; Z, Kenderessy AS, et al. A mannose-binding receptor is expressed on human keratinocytes and mediates killing of Candida albicans. J Invest Dermatol 2001; 117:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/99\">",
"      Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/100\">",
"      Varadaradjalou S, F&eacute;ger F, Thieblemont N, et al. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur J Immunol 2003; 33:899.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/101\">",
"      McCurdy JD, Olynych TJ, Maher LH, Marshall JS. Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J Immunol 2003; 170:1625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/102\">",
"      Schulman ES, Post TJ, Henson PM, Giclas PC. Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release. J Clin Invest 1988; 81:918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/103\">",
"      Malaviya R, Ikeda T, Ross E, Abraham SN. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 1996; 381:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/104\">",
"      Abraham SN, St John AL. Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol 2010; 10:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/105\">",
"      Semple JW, Freedman J. Platelets and innate immunity. Cell Mol Life Sci 2010; 67:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/106\">",
"      Leslie M. Cell biology. Beyond clotting: the powers of platelets. Science 2010; 328:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/107\">",
"      Holt PG, Oliver J, Bilyk N, et al. Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J Exp Med 1993; 177:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/108\">",
"      Lambrecht BN. Alveolar macrophage in the driver's seat. Immunity 2006; 24:366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/109\">",
"      Takabayshi K, Corr M, Hayashi T, et al. Induction of a homeostatic circuit in lung tissue by microbial compounds. Immunity 2006; 24:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/110\">",
"      Silva MT. Bacteria-induced phagocyte secondary necrosis as a pathogenicity mechanism. J Leukoc Biol 2010; 88:885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/111\">",
"      Banerjee S, Friggeri A, Liu G, Abraham E. The C-terminal acidic tail is responsible for the inhibitory effects of HMGB1 on efferocytosis. J Leukoc Biol 2010; 88:973.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/112\">",
"      Fadok VA, Voelker DR, Campbell PA, et al. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992; 148:2207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/113\">",
"      Fadok VA, Bratton DL, Rose DM, et al. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 2000; 405:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/114\">",
"      Fadeel B, Xue D, Kagan V. Programmed cell clearance: molecular regulation of the elimination of apoptotic cell corpses and its role in the resolution of inflammation. Biochem Biophys Res Commun 2010; 396:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/115\">",
"      Parihar A, Eubank TD, Doseff AI. Monocytes and macrophages regulate immunity through dynamic networks of survival and cell death. J Innate Immun 2010; 2:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/116\">",
"      Johnston RB Jr. Clinical aspects of chronic granulomatous disease. Curr Opin Hematol 2001; 8:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/117\">",
"      Segal BH, Han W, Bushey JJ, et al. NADPH oxidase limits innate immune responses in the lungs in mice. PLoS One 2010; 5:e9631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/118\">",
"      Fernandez-Boyanapalli RF, Frasch SC, McPhillips K, et al. Impaired apoptotic cell clearance in CGD due to altered macrophage programming is reversed by phosphatidylserine-dependent production of IL-4. Blood 2009; 113:2047.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/119\">",
"      Fernandez-Boyanapalli R, McPhillips KA, Frasch SC, et al. Impaired phagocytosis of apoptotic cells by macrophages in chronic granulomatous disease is reversed by IFN-&gamma; in a nitric oxide-dependent manner. J Immunol 2010; 185:4030.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/37/16986/abstract/120\">",
"      Vandivier RW, Ogden CA, Fadok VA, et al. Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex. J Immunol 2002; 169:3978.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13572 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-58.240.98.179-F8E45503D2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_37_16986=[""].join("\n");
var outline_f16_37_16986=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H9421100\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9420958\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23899400\">",
"      COMPONENTS AND FUNCTIONS OF THE INNATE IMMUNE SYSTEM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9420979\">",
"      INNATE VERSUS ADAPTIVE IMMUNITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9420986\">",
"      MICROBIAL DETECTION THROUGH PATTERN RECOGNITION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9420994\">",
"      Pattern recognition in innate immunity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9421001\">",
"      Pathogen-associated molecular patterns",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9421008\">",
"      PROTOTYPIC PRRs: SECRETED AND CIRCULATING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9421016\">",
"      Antimicrobial peptides",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9421023\">",
"      Collectins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9421030\">",
"      Lectins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9421037\">",
"      Pentraxins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9421192\">",
"      PROTOTYPIC PRRs: CELL-ASSOCIATED",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9421044\">",
"      Toll-like receptors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9421051\">",
"      PRRs linked to phagocytosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9421058\">",
"      Intracellular PRRs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9421065\">",
"      CELLS OF THE INNATE IMMUNE SYSTEM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9421072\">",
"      Neutrophils",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9421079\">",
"      Monocytes and macrophages",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9421086\">",
"      Natural killer cells",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9421093\">",
"      Other cell types",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5719882\">",
"      HOMEOSTASIS IN THE INNATE IMMUNE SYSTEM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9421100\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/13572\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/13572|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/35/24124\" title=\"table 1\">",
"      Secreted and circulating pattern recognition receptors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/50/39724\" title=\"table 2\">",
"      Cell associated pattern recognition receptors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?13/25/13724\" title=\"table 3\">",
"      Toll-like receptors",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/42/38569?source=related_link\">",
"      Acute phase reactants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/53/25432?source=related_link\">",
"      Antigen presenting cells",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/36/10826?source=related_link\">",
"      Chronic granulomatous disease: Pathogenesis, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/59/11190?source=related_link\">",
"      Complement pathways",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/22/24937?source=related_link\">",
"      Congenital neutropenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27401?source=related_link\">",
"      Immune and microbial mechanisms in the pathogenesis of inflammatory bowel disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/54/36711?source=related_link\">",
"      Leukocyte-endothelial adhesion in the pathogenesis of inflammation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/8/12420?source=related_link\">",
"      Mannose-binding lectin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/14/19690?source=related_link\">",
"      Mannose-binding lectin deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/6/34921?source=related_link\">",
"      Mast cell derived mediators",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/22/44393?source=related_link\">",
"      Mast cells: Development, identification, and physiologic roles",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/28/20936?source=related_link\">",
"      Mast cells: Surface receptors and signal transduction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/10/30889?source=related_link\">",
"      NK cell deficiency syndromes: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/38/43620?source=related_link\">",
"      Primary disorders of phagocytic function: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/58/6056?source=related_link\">",
"      The adaptive cellular immune response",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27624?source=related_link\">",
"      The humoral immune response",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/54/23401?source=related_link\">",
"      Toll-like receptors: Roles in disease and therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/29/31193?source=related_link\">",
"      Vitamin D and extraskeletal health",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_37_16987="Travel tips PI";
var content_f16_37_16987=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F71028&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F71028&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Tips to avoid lower leg swelling and deep vein thrombosis during prolonged travel",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        All travelers should consider the following recommendations for flights longer than six to eight hours:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <ul>",
"         <li>",
"          Stand up and walk around every hour or two",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <ul>",
"         <li>",
"          Avoid smoking prior to travel",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <ul>",
"         <li>",
"          Wear loose-fitting, comfortable clothing",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <ul>",
"         <li>",
"          Request bulkhead or emergency row seating when possible",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <ul>",
"         <li>",
"          Flex and extend the ankles and knees periodically, avoid crossing the legs, and change positions frequently while seated",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <ul>",
"         <li>",
"          Consider wearing knee-high compression stockings",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <ul>",
"         <li>",
"          Avoid medications (eg, sedatives, sleeping pills) or alcohol, which could impair your ability to get up and move around",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_37_16987=[""].join("\n");
var outline_f16_37_16987=null;
var title_f16_37_16988="Proposed criteria for ET";
var content_f16_37_16988=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F52174&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F52174&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Proposed revised WHO criteria for essential thrombocythemia (ET)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Proposed criteria for ET",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sustained platelet count &ge;450 x 10",
"        <sup>",
"         9",
"        </sup>",
"        /L*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bone marrow biopsy specimen showing proliferation mainly of the megakaryocytic lineage with increased numbers of enlarged, mature megakaryocytes; no significant increase or left-shift of neutrophil granulopoiesis or erythropoiesis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Not meeting WHO criteria for PV",
"        <sup>",
"         &bull;",
"        </sup>",
"        , PMF",
"        <sup>",
"         &Delta;",
"        </sup>",
"        , CML",
"        <sup>",
"         &loz;",
"        </sup>",
"        , MDS",
"        <sup>",
"         &sect;",
"        </sup>",
"        or other myeloid neoplasm",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Demonstration of JAK2 617V&gt;F or other clonal marker, or in the absence of a clonal marker, no evidence for reactive thrombocytosis",
"        <sup>",
"         &yen;",
"        </sup>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Diagnosis requires meeting all&nbsp;four criteria.",
"    <div class=\"footnotes\">",
"     * During the work-up period.",
"     <br>",
"      &bull; Requires the failure of iron replacement therapy to increase hemoglobin level to the PV range in the presence of decreased serum ferritin. Exclusion of PV is based on hemoglobin and hematocrit levels, and red cell mass measurement is not required.",
"      <br>",
"       &Delta; Requires the absence of relevant reticulin fibrosis, collagen fibrosis, peripheral blood leukoerythroblastosis, or markedly hypercellular marrow for age accompanied by megakaryocyte morphology that is typical for PMF-small to large with an aberrant nuclear/cytoplasmic ratio and hyperchromatic, bulbous or irregularly folded nuclei and dense clustering.",
"       <br>",
"        &loz; Requires the absence of BCR-ABL.",
"        <br>",
"         &sect; Requires absence of dyserythropoiesis and dysgranulopoiesis.",
"         <br>",
"          &yen; Causes of reactive thrombocytosis include iron deficiency, splenectomy, surgery, infection, inflammation, connective tissue disease, metastatic cancer, and lymphoproliferative disorders. However, the presence of a condition associated with reactive thrombocytosis does not exclude the possibility of ET if the first three criteria are met.",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Tefferi A, Thiele J, Orazi A, et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood 2007; 110:1092. Copyright &copy;2007 American Society of Hematology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_37_16988=[""].join("\n");
var outline_f16_37_16988=null;
var title_f16_37_16989="Enterovirus dissemination";
var content_f16_37_16989=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F73829&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F73829&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pathogenesis of enterovirus infection: replication and dissemination",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 352px; height: 318px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_37_16989=[""].join("\n");
var outline_f16_37_16989=null;
var title_f16_37_16990="Immunization for travel";
var content_f16_37_16990=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F82688&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F82688&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Some immunizations for travel",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"5\" width=\"20%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Vaccines",
"       </td>",
"       <td class=\"subtitle1\">",
"        Adult dose",
"       </td>",
"       <td class=\"subtitle1\">",
"        Pediatric age/dose",
"       </td>",
"       <td class=\"subtitle1\">",
"        Standard primary schedule",
"       </td>",
"       <td class=\"subtitle1\">",
"        Duration of protection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Hepatitis A",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Havrix (GSK)",
"       </td>",
"       <td>",
"        1 mL IM (1440 EU)",
"       </td>",
"       <td>",
"        1 to 18 years: 0.5 mL IM (720 EU)",
"       </td>",
"       <td>",
"        0 and 6 to 12 months",
"       </td>",
"       <td rowspan=\"2\">",
"        Probably lifelong after completion of primary series*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Vaqta (Merck)",
"       </td>",
"       <td>",
"        1 mL IM (50 U)",
"       </td>",
"       <td>",
"        1 to 18 years: 0.5 mL IM (25 U)",
"       </td>",
"       <td>",
"        0 and 6 to 18 months",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Hepatitis B",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Engerix-B (GSK)",
"       </td>",
"       <td>",
"        1 mL IM (20 mcg)",
"       </td>",
"       <td>",
"        Birth to 19 years: 0.5 mL IM (10 mcg)",
"       </td>",
"       <td>",
"        0, 1 and 6 months",
"        <sup>",
"         &bull;&Delta;",
"        </sup>",
"       </td>",
"       <td rowspan=\"2\">",
"        Probably lifelong after completion of primary series",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Recombivax-HB (Merck)",
"       </td>",
"       <td>",
"        1 mL IM (10 mcg)",
"       </td>",
"       <td>",
"        Birth to 19 years: 0.5 mL IM (5 mcg)",
"       </td>",
"       <td>",
"        0, 1 and 6 months",
"        <sup>",
"         &Delta;&loz;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Hepatitis A/B",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Twinrix (GSK)",
"       </td>",
"       <td>",
"        1 mL IM (720 EU/20 mcg)",
"       </td>",
"       <td>",
"        Not approved for &lt;18 years",
"       </td>",
"       <td>",
"        0, 1 and 6 months (alternative: 0, 7 and 21-30 days)",
"       </td>",
"       <td>",
"        Booster recommended at 12 months with accelerated schedule; otherwise probably lifelong after completion of primary series",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Japanese encephalitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ixiaro (Novartis)",
"       </td>",
"       <td>",
"        0.5 mL IM",
"       </td>",
"       <td>",
"        Not approved for &lt;17 years",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        0, 28 days",
"       </td>",
"       <td>",
"        A single booster &gt;1 year after completion of primary series if ongoing risk",
"        <sup>",
"         &yen;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Meningococcal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Menomune (Sanofi Pasteur)",
"       </td>",
"       <td>",
"        0.5 mL SC (50 mcg of each antigen)",
"       </td>",
"       <td>",
"        &ge;2 years: 0.5 mL SC (50 mcg of each antigen)",
"       </td>",
"       <td>",
"        Single dose",
"       </td>",
"       <td>",
"        Repeat every 5 years",
"        <sup>",
"         ������",
"        </sup>",
"        with Menactra or Menveo if ongoing risk",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Menveo (Novartis)",
"       </td>",
"       <td>",
"        0.5 mL IM (10 mcg serogroup A, 5 mcg serogroup C, Y, W135)",
"       </td>",
"       <td>",
"        &ge;2 years: 0.5 mL IM (10 mcg serogroup A, 5 mcg serogroup C, Y, W135)",
"       </td>",
"       <td>",
"        &ge;2 to 55 years: single dose",
"        <sup>",
"         ������",
"        </sup>",
"       </td>",
"       <td>",
"        Repeat every 5 years",
"        <sup>",
"         ������",
"        </sup>",
"        if ongoing risk",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Menactra (Sanofi Pasteur)",
"       </td>",
"       <td>",
"        0.5 mL IM (4 mcg of each antigen)",
"       </td>",
"       <td>",
"        &ge;9 months: 0.5 mL IM 4 mcg of each antigen",
"       </td>",
"       <td>",
"        <p>",
"         9 to 23 months: 0, 3 months",
"        </p>",
"        &ge;2-55 years: single dose",
"       </td>",
"       <td>",
"        Repeat every 5 years",
"        <sup>",
"         ������",
"        </sup>",
"        if ongoing risk",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Rabies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Imovax (Sanofi Pasteur)",
"       </td>",
"       <td>",
"        1 mL IM (&ge;2.5 IU of rabies antigen)",
"       </td>",
"       <td>",
"        Birth: 1 mL IM (&ge;2.5 IU of rabies antigen)",
"       </td>",
"       <td>",
"        0, 7 and 21 or 28 days**",
"       </td>",
"       <td rowspan=\"2\">",
"        Routine boosters not necessary; for those engaging in frequent high-risk activities (cavers, veterinarians, laboratory workers), serologic testing is recommended every 2 years with booster doses if low levels",
"        <sup>",
"         &bull;&bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        RabAvert (Novartis)",
"       </td>",
"       <td>",
"        1 mL IM (&ge;2.5 IU of rabies antigen)",
"       </td>",
"       <td>",
"        Birth: 1 mL IM (&ge;2.5 IU of rabies antigen)",
"       </td>",
"       <td>",
"        0, 7 and 21 or 28 days**",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Typhoid",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Vivotif (Crucell/Berna)",
"       </td>",
"       <td>",
"        1 cap PO (contains 2-6x10** viable CFU of S. Typhi Ty21a)",
"       </td>",
"       <td>",
"        &ge;6 years: 1 cap PO (contains 2-6x10** viable CFU of S. Typhi Ty21a)",
"       </td>",
"       <td>",
"        1 cap every other day x 4 doses",
"       </td>",
"       <td>",
"        Repeat every 5 years if ongoing risk",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Typhim Vi (Sanofi Pasteur)",
"       </td>",
"       <td>",
"        0.5 mL IM (25 mcg)",
"       </td>",
"       <td>",
"        &ge;2 years: 0.5 mL IM (25 mcg)",
"       </td>",
"       <td>",
"        Single dose",
"       </td>",
"       <td>",
"        Repeat every 2 years (3 years in Canada) if ongoing risk",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Yellow fever",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        YF-Vax (Sanofi Pasteur)",
"       </td>",
"       <td>",
"        0.5 mL SC (4.74 log",
"        <sup>",
"         &bull;&bull;",
"        </sup>",
"        plaque forming units of 17D204 attenuated YF virus)",
"       </td>",
"       <td>",
"        &ge;9 months: 0.5 mL SC (4.74 log",
"        <sup>",
"         &bull;&bull;",
"        </sup>",
"        plaque forming units of 17D204 attenuated YF virus)",
"       </td>",
"       <td>",
"        Single dose",
"       </td>",
"       <td>",
"        Booster dose every 10 years if ongoing risk",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Protection likely lasts at least 12 months after a single dose.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     An alternate schedule is three doses given at 0, 1, and 2 months, followed by a fourth dose at 12 months.",
"     <br/>",
"     &Delta; An accelerated schedule of 0, 7, and 14 days followed by a booster dose at 6 months has been used, but is not FDA-approved.",
"     <br/>",
"     <span class=\"lozenge\">",
"      &loz;",
"     </span>",
"     An alternate schedule for adolescents 11 to 15 years old is 0 and 4 to 6 months.",
"     <br/>",
"     &sect; One study found that Ixiaro administered at half the adult dose was safe and induced a good immune response in children 1 to 3 years old",
"     <sup>",
"      [1]",
"     </sup>",
"     . The adult dose is under investigation for use in children &ge;3 years old.",
"     <br/>",
"     &yen; Adults previously vaccinated with JE Vax should receive a primary series of Ixiaro",
"     <sup>",
"      [2]",
"     </sup>",
"     .",
"     <br/>",
"     &Dagger; Repeat after 3 years for children vaccinated at &lt;7 years of age.",
"     <br/>",
"     &dagger; For children 2 to 5 years old at continued high risk, a second dose may be administered 2 months after the first.",
"     <br/>",
"     ** Regimen for pre-exposure prophylaxis. If a previously vaccinated traveler is exposed to a potentially rabid animal, post-exposure prophylaxis with 2 additional vaccine doses separated by 3 days should be initiated as soon as possible.",
"     <br/>",
"     <span class=\"double_bullet\">",
"      &bull;&bull;",
"     </span>",
"     Minimal acceptable antibody level is complete virus neutralization at a 1:5 serum dilution by the rapid fluorescent focus inhibition test.",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <ol>",
"      <li>",
"       Kaltenb&ouml;ck A, Dubischar-Kastner K, Schuller E, et al. \"Immunogenicity and safety of IXIARO (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age. Vaccine 2010; 28:834.",
"      </li>",
"      <li>",
"       Centers for Disease Control and Prevention (CDC). Recommendations for use of a booster dose of inactivated vero cell culture-derived Japanese encephalitis vaccine: Advisory committee on immunization practices, 2011. MMWR Morb Mortal Wkly Rep 2011; 60:661.",
"      </li>",
"     </ol>",
"     Reprinted with special permission from: Treatment Guidelines from The Medical Letter, June 2012; Vol. 10 (118):45.",
"     <a href=\"file://www.medicalletter.org\" style=\"FONT-STYLE: italic\" target=\"_blank\">",
"      www.medicalletter.org",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_37_16990=[""].join("\n");
var outline_f16_37_16990=null;
var title_f16_37_16991="Primary hyperfibrinolysis";
var content_f16_37_16991=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F51767&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F51767&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 613px\">",
"   <div class=\"ttl\">",
"    Primary hyperfibrinolysis as assessed by thromboelastography",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 593px; height: 273px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Citrated rapid thromboelastography study&nbsp;(rapid-TEG)&nbsp;showing primary hyperfibrinolysis. The red tracing indicates a normal study.",
"    <br>",
"     This study has a normal ACT, normal R time, normal K time, and normal alpha angle; low MA and G, reflecting significant fibrinolysis prior to achieving maximal clot strength; high LY30 reflecting hyperfibrinolysis.",
"     <div class=\"footnotes\">",
"      R (reaction time): time from sample placement or activation until the tracing amplitude reaches 2 mm; K (clot formation time): time elapsed between the R-time and the point where the tracing amplitude reaches 20 mm; alpha angle: angle between the middle line of the tracing and a tangential line to the developing \"body\" of the tracing; MA (maximal amplitude): the maximal amplitude reached after clot initiation; G: a calculated measure of total clot strength based on amplitude; LY30: the amount of clot lysis detected 30 minutes after the maximal amplitute (MA) is reached; SP (split point): time from sample placement (or activation with an exogenous procoagulant) until the earliest detectable resistance.",
"     </div>",
"     <div class=\"reference\">",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_37_16991=[""].join("\n");
var outline_f16_37_16991=null;
